medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Title
High variability in transmission of SARS-CoV-2 within households and implications for control
Authors
Damon J.A. Toth1,2,3, Alexander B. Beams1,3, Lindsay T. Keegan1,2, Yue Zhang1, Tom Greene1, Brian Orleans1,
Nathan Seegert4, Adam Looney4, Stephen C. Alder5, Matthew H. Samore1,2
Affiliations
1

Department of Internal Medicine, University of Utah School of Medicine

2

Department of Veterans Affairs Salt Lake City Healthcare System

3

Department of Mathematics, University of Utah

4

Department of Finance, University of Utah David Eccles School of Business

5

Department of Family and Preventive Medicine, University of Utah School of Medicine

Correspondence
Damon J.A. Toth
295 Chipeta Way
Salt Lake City, Utah 84132
Damon.Toth@hsc.utah.edu
Abstract
Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a high risk of transmission in
close-contact indoor settings, which may include households. Prior studies have found a wide range of household
secondary attack rates and may contain biases due to simplifying assumptions about transmission variability and test
accuracy.

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Methods. We compiled serological SARS-CoV-2 antibody test data and prior SARS-CoV-2 test reporting from
members of 9,224 Utah households. We paired these data with a probabilistic model of household importation and
transmission. We calculated a maximum likelihood estimate of the importation probability, mean and variability of
household transmission probability, and sensitivity and specificity of test data. Given our household transmission
estimates, we estimated the threshold of non-household transmission required for epidemic growth in the population.
Results. We estimated that individuals in our study households had a 0.41% (95% CI 0.32% â€“ 0.51%) chance of
acquiring SARS-CoV-2 infection outside their household. Our household secondary attack rate estimate was 36%
(27% â€“ 48%), substantially higher than the crude estimate of 16% unadjusted for imperfect serological test
specificity and other factors. We found evidence for high variability in individual transmissibility, with higher
probability of no transmissions or many transmissions compared to standard models. With household transmission at
our estimates, the average number of non-household transmissions per case must be kept below 0.41 (0.33 â€“ 0.52) to
avoid continued growth of the pandemic in Utah.
Conclusions. Our findings suggest that crude estimates of household secondary attack rate based on serology data
without accounting for false positive tests may underestimate the true average transmissibility, even when test
specificity is high. Our finding of potential high variability (overdispersion) in transmissibility of infected
individuals is consistent with characterizing SARS-CoV-2 transmission being largely driven by superspreading from
a minority of infected individuals. Mitigation efforts targeting large households and other locations where many
people congregate indoors might curb continued spread of the virus.

1 Introduction
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible
for COVID-19, has spread rapidly, causing severe morbidity, mortality, and disruption to daily life. As public health
officials continue grappling with reducing community spread, it is of increased importance to understand
transmission risk in different locations where people mix. Transmission within households may be especially
important, given the mounting evidence that indoor environments with close, sustained contact are especially high
risk for SARS-CoV-2 transmission [1-3]. Furthermore, with substantial observed decreases in mobility during the

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

pandemic [4], individuals likely are spending a greater proportion of time at home, thus increasing the importance of
understanding within-household transmission. Likewise, isolation and quarantine measures recommended to help
control COVID-19 frequently occur within homes, increasing risk to susceptible household members [5].
Data collected from members of households with at least one person infected with SARS-CoV-2 have revealed a
wide range of within-household transmission estimates. One systematic review and meta-analysis [6] found 24
studies with household data conducted from January-March 2020, mostly in China, with secondary attack rate
estimates ranging from 5% to 90% in the individual studies; pooling these data led to an average secondary attack
rate estimate of 27% (95% CI: 21% â€“ 32%). Another published review and meta-analysis of more recent data found
22 studies on the secondary attack rate in households, including estimates ranging from 4% to 32% [7]. Pooling
these studies, the review found an average secondary attack rate of 17.1% (95% CI: 13.7% â€“ 21.2%). Another
review and meta-analysis found 40 household studies with individual study estimates ranging from 4% to 45% [8].
Their pooled analysis found that the household-based secondary attack rate for all household contacts was 19.0%
(95% CI: 14.9 â€“ 23.1%). Data from households in the U.S. [9-12] produced secondary attack rate estimates from
11% to 53%.
Most household studies generated data by first identifying index household cases via active or passive surveillance
followed by monitoring and testing specimens from their household contacts using PCR or other methods that detect
presence of the virus. These studies may exhibit bias if mild or asymptomatic cases were less likely to be identified
as an index household case. By contrast, data for the presence of antibodies among household members provide
information on the distribution of final sizes of household outbreaks no longer in progress and in which some or
none of the cases were identified at the time. We are aware of only 3 studies that used serological antibody data to
estimate household transmission, using data from Spain [13], Brazil [14], and Switzerland [15].
In addition to average transmission rates, heterogeneity and variability in SARS-CoV-2 transmission have also been
quantified. The amount of individual-level variation in the number of secondary infections can affect final outbreak
size [16]. Large variation (i.e., overdispersion) indicates the presence of superspreading by a minority of individuals
who transmit to a disproportionately large number of others [17]. Better understanding of superspreading individuals
and locations can greatly enhance efficient targeting of transmission control strategies [18]. Backward contact
tracing can efficiently trace sources of acquisition to high-transmission individuals and circumstances when

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

superspreading is present [19], and efforts that target similar circumstances for transmission prevention can have
disproportionate benefits [20, 21].
Studies have quantified the variability in the number of SARS-CoV-2 transmissions from infected individuals using
the dispersion parameter ğ‘˜, governing the variance of a negative binomially distributed offspring distribution [2226]. Those studies estimated high overdispersion (low values of ğ‘˜) similar to what was observed during the first
SARS-CoV outbreak in 2003 [17]. These estimates were derived from data on transmissions, including
superspreading events, occurring in a variety of locations both inside and outside of households. Regarding
household transmission specifically, Madewell et al. [8] showed preliminary evidence of overdispersion in
household data, with more households than expected experiencing extremes of transmission (i.e., either no
transmission or many transmissions) from an introduced case.
In this study, we combine SARS-CoV-2 data from serological antibody tests and self-reported prior tests to estimate
within-household transmission of COVID-19 in Utah. Previously published secondary attack rate estimates are
largely based on crude formulae which ignore the probabilities of multiple members of a household acquiring
infection from the community, multiple generations of transmission within the household (i.e. secondary, tertiary,
etc. transmissions), and imperfect test sensitivity and specificity. We addressed these limitations by extending
previous models of final household outbreak size distributions [27] to develop a novel probabilistic model of
household importation and household transmission combined with test sensitivity and specificity. Our model also
quantifies variability in household transmission and the potential extent of overdispersion, to shed light on
superspreading phenomena and the implications of household transmission for population-level controllability of
COVID-19.
2 Methods
2.1 Data collection from Utah households
Details of our data collection process are described elsewhere [28]. Briefly, the Utah Health & Economic Recovery
Outreach project involved selecting households in several counties in Utah by population sampling designed to form
a set of households by which average community seroprevalence could be assessed. Any member of selected
households could participate in a survey that included questions about prior SARS-CoV-2 test results (see

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Supplementary Methods for wording of relevant survey questions). Adult household members could fill out surveys
on behalf of children of any age in the household. Survey participants age 12 or older could additionally opt to
provide serological samples for COVID-19 antibody testing. Serum specimens were analyzed using the Abbott
SARS-CoV-2 IgG assay performed on an Abbott Architect i2000 instrument (Abbott Laboratories), with
methodology and criteria for a positive antibody result defined according to the manufacturerâ€™s instructions. Data
included in this analysis were collected between May 4 and August 15, 2020.
The University of Utah Institutional Review Board reviewed the surveillance project that produced the data analyzed
in this manuscript and determined it as non-research public health surveillance, waived the requirement for
documented consent, and determined that use of these data for analysis to understand the dynamics of SARS-CoV-2
transmission was exempt from further review (IRB_00132598). Individuals were informed of the project procedures
and that participation was voluntary. Participants provided their agreement to participate and were given the chance
to opt out of having their data used for future research. The data were analyzed anonymously for this manuscript.
The data are represented as follows. For each household in the dataset, we captured the following 7 values from the
data:
â€¢

ğ‘›: total number of people in household

â€¢

ğ‘: number who were antibody tested

â€¢

ğ‘ : number who responded to the survey but were not antibody tested

â€¢

ğ‘ğ‘ƒğ‘ƒ : number who reported a prior positive test result and received a positive antibody test

â€¢

ğ‘ğ‘ƒğ‘ : number who reported a prior positive test result and received a negative antibody test

â€¢

ğ‘ğ‘ğ‘ƒ : number who reported no prior positive test result and received a positive antibody test

â€¢

ğ‘ ğ‘ƒ : number who were surveyed, reported a prior positive test result, and did not receive an antibody test

Those surveyed participants who reported no prior positive test result includes both those who had never been tested
and those who had been tested but received no positive results. We did not have sufficient information to properly
distinguish those two groups, nor to determine the circumstances of any prior negative tests that might affect the
inferred probability of true prior infection.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Each of the ğ¶ unique combinations of the above 7 values found at least once in the dataset was indexed as a vector
ğ²ğ‘– :
ğ²ğ‘– = (ğ‘›ğ‘– , ğ‘ğ‘– , ğ‘ ğ‘– , ğ‘ğ‘ƒğ‘ƒğ‘– , ğ‘ğ‘ƒğ‘ğ‘– , ğ‘ğ‘ğ‘ƒğ‘– , ğ‘ ğ‘ƒğ‘– )
We tallied the number of households for which each ğ²ğ‘– occurred in the frequency elements ğ‘“ğ‘– , and represented the
entire dataset by the vector ğ² = (ğ²1 , â€¦ , ğ²ğ¶ , ğ‘“1 , â€¦ ğ‘“ğ¶ ).
The dataset ğ² and all codes, written in R version 4.0.3, used for analyses described in the following sections are
posted and publicly available at https://github.com/damontoth/householdTransmission.
2.2 Total household infection size model
Here we derive the probabilities ğ‘€ğ‘˜ğ‘› for the probability that ğ‘˜ out of ğ‘› total household members ended up infected.
If ğ‘˜ members of a size-ğ‘› household were infected, that means that ğ‘› âˆ’ ğ‘˜ members escaped being infected by a nonhousehold member (called â€œcommunityâ€ acquisitions) and escaped being infected by any of the ğ‘› infected within the
household. Thus, our model for ğ‘€ğ‘˜ğ‘› combines both probabilities and does not depend on the order of occurrence of
household transmissions and subsequent community acquisitions after the initial one, as in similar prior formulations
[27]. Also following prior formulations, we assume that active infections were not present in the households at the
time of antibody data collection (i.e., that household outbreaks had reached final size). Accounting for the timing of
recent household importations, transmissions, and development of detectable antibodies during an ongoing
household outbreak would significantly complicate the model equations and would likely have little effect on our
overall results, given that the prevalence of active infections at the time of data collection was very low [28].
The ğ‘€ğ‘˜ğ‘› values depend on 3 parameters. The parameter ğ‘ğ‘ is the average per-capita probability of community
acquisition, ğ‘â„ is the mean transmission probability from an infected person to a fellow household member, and ğ‘‘â„
is the dispersion parameter characterizing variability in transmissibility across infected individuals, with no assumed
correlation among members of the same household.
For a given household size ğ‘› â‰¥ 2, the formula for ğ‘€ğ‘˜ğ‘› is:

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

(1 âˆ’ ğ‘ğ‘ )ğ‘› ,

ğ‘˜=0

ğ‘˜

ğ‘€ğ‘˜ğ‘› (ğ‘ğ‘ , ğ‘â„ , ğ‘‘â„ ) =

ğ‘›
âˆ‘ ( ) (ğ‘ğ‘ )ğ‘– (1 âˆ’ ğ‘ğ‘ )ğ‘›âˆ’ğ‘– ğ‘‡ğ‘–,ğ‘˜âˆ’ğ‘–,ğ‘›âˆ’ğ‘– (ğ‘â„ , ğ‘‘â„ ) , ğ‘˜ = 1, â€¦ , ğ‘› âˆ’ 1
ğ‘–
ğ‘–=1

ğ‘›âˆ’1

1 âˆ’ âˆ‘ ğ‘€ğ‘˜ğ‘› (ğ‘ğ‘ , ğ‘â„ , ğ‘‘â„ ) ,

{

ğ‘˜=ğ‘›

ğ‘˜=0

For households of size ğ‘› = 1, note that the expression involving the household transmission parameters does not
apply and we have ğ‘€01 = 1 âˆ’ ğ‘ğ‘ and ğ‘€11 = ğ‘ğ‘ .
The probability that a household of size ğ‘› had 0 infections: ğ‘€0ğ‘› = (1 âˆ’ ğ‘ğ‘ )ğ‘› , is the probability that none of the
household members acquired infection from the community and does not depend on the household transmission
variables because no household transmissions were possible without a community introduction. For the final number
of household infections to be nonzero, there must be at least one community acquisition, which may be followed by
ğ‘›
within-household transmissions. The ( ) (ğ‘ğ‘ )ğ‘– (1 âˆ’ ğ‘ğ‘ )ğ‘›âˆ’ğ‘– expression is the binomial probability that ğ‘– out of the ğ‘›
ğ‘–
household members had a community acquisition, and the function ğ‘‡ğ‘¥ğ‘¦ğ‘§ is the probability that ğ‘¥ already infected
household members lead to a total of ğ‘¦ transmissions to ğ‘§ susceptible household members. In other words, ğ‘‡ğ‘¥ğ‘¦ğ‘§ is
the probability that the final outbreak size is ğ‘¥ + ğ‘¦, given that ğ‘¥ household members are already infected in a house
with ğ‘§ susceptible members. For efficiency of computation, the ğ‘‡ğ‘¥ğ‘¦ğ‘§ values are calculated in order of increasing
values of ğ‘¦, i.e. ğ‘‡ğ‘¥0ğ‘§ for each relevant ğ‘¥ and ğ‘§ value are calculated first, then the ğ‘‡ğ‘¥1ğ‘§ values, then ğ‘‡ğ‘¥2ğ‘§ . This allows
the use of ğ‘‡ğ‘¥ğ‘¦ğ‘§ values for lower values of ğ‘¦ to be used in the formula (see Supplementary Material for details):
ğ»ğ‘¥0ğ‘§ (ğ‘â„ , ğ‘‘â„ ),

ğ‘¦=0

ğ‘¦âˆ’1

ğ‘‡ğ‘¥ğ‘¦ğ‘§ (ğ‘â„ , ğ‘‘â„ ) = {

âˆ‘ ğ»ğ‘¥,ğ‘¦âˆ’ğ‘–,ğ‘§ (ğ‘â„ , ğ‘‘â„ )ğ‘‡ğ‘¦âˆ’ğ‘–,ğ‘–,ğ‘§âˆ’ğ‘¦+ğ‘– (ğ‘â„ , ğ‘‘â„ ) , ğ‘¦ = 1, â€¦ , ğ‘›
ğ‘–=0

Within the ğ‘‡ğ‘¥ğ‘¦ğ‘§ formula, the function ğ»ğ‘¥ğ‘¦ğ‘§ is the probability that ğ‘¥ infected household members transmit infection
directly to ğ‘¦ out of ğ‘§ fellow household members who are susceptible. The ğ»ğ‘¥ğ‘¦ğ‘§ values are calculated in order of
increasing values of ğ‘¥ for efficient computation (see Supplementary Material):

ğ»ğ‘¥ğ‘¦ğ‘§ (ğ‘â„ , ğ‘‘â„ ) = {

ğ¹ğ‘¦ğ‘§ (ğ‘â„ , ğ‘‘â„ ),

ğ‘¥=1

âˆ‘ ğ»ğ‘¥âˆ’1,ğ‘–,ğ‘§ (ğ‘â„ , ğ‘‘â„ )ğ»1,ğ‘¦âˆ’ğ‘–,ğ‘§âˆ’ğ‘– (ğ‘â„ , ğ‘‘â„ ) ,

ğ‘¥ = 2, â€¦ , ğ‘› âˆ’ 1

ğ‘¦

ğ‘–=0

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Finally, the function ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) is the probability mass function of the beta-binomial distribution for ğ‘¦ successes out
of ğ‘§ trials, parameterized by a mean success probability ğ‘ and a dispersion parameter ğ‘‘. When ğ‘‘ is finite and
nonzero, ğ¹ğ‘¦ğ‘§ is derived from the binomial distribution with success probability that is a beta-distributed random
variable with parameters ğ›¼ = ğ‘‘ğ‘, ğ›½ = ğ‘‘(1 âˆ’ ğ‘), with decreasing variance as ğ‘‘ increases. We also make use of the
boundary cases ğ‘‘ = 0 and ğ‘‘ â†’ âˆ. In the limit ğ‘‘ â†’ âˆ, holding ğ‘ constant, ğ¹ğ‘¦ğ‘§ becomes the binomial distribution
with constant success probability ğ‘ (Supplementary Material). In the maximal variance limit, ğ‘‘ â†’ 0, with ğ‘ held
constant, ğ¹ğ‘¦ğ‘§ becomes an â€œall-or-nothingâ€ distribution where ğ‘¦ = ğ‘§ successes occur with probability ğ‘ and to ğ‘¦ = 0
successes occur with probability 1 âˆ’ ğ‘ (Supplementary Material):
1 âˆ’ ğ‘,
ğ‘¦=0
0 < ğ‘¦ < ğ‘§,
{ 0,
ğ‘,
ğ‘¦=ğ‘§
ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) = ğ‘§ B(ğ‘¦ + ğ‘‘ğ‘, ğ‘§ âˆ’ ğ‘¦ + ğ‘‘(1 âˆ’ ğ‘))
,
(ğ‘¦ )
B(ğ‘‘ğ‘, ğ‘‘(1 âˆ’ ğ‘))
ğ‘§
(ğ‘¦) ğ‘ ğ‘¦ (1 âˆ’ ğ‘)ğ‘§âˆ’ğ‘¦ ,
{

ğ‘‘=0
0<ğ‘‘<âˆ
ğ‘‘â†’âˆ

The function B is the beta function. We use ğ¹ğ‘¦ğ‘§ within the formula for ğ»1ğ‘¦ğ‘§ to quantify the distribution of household
transmissions directly from a single infected household member, where ğ‘¦ is the number of transmissions, ğ‘§ is the
number of susceptible household members, ğ‘ = ğ‘â„ , and ğ‘‘ = ğ‘‘â„ .
The above formulas are derived in the Supplementary Material. Elements of this model appear in other publications.
Longini and Koopman [27] derived a formula for ğ‘€ğ‘˜ğ‘› for the model with no variability among households or
individuals, equivalent to our model with ğ‘‘â„ â†’ âˆ. While they provided a more efficient formula that takes
advantage of the properties of that special case, we confirmed that our calculation scheme above reproduces the
results of their formula. Becker [29] published explicit formulas for the final size of household outbreaks after a
single introduction to households up to size 5 using the beta-binomial chain model, equivalent to our ğ‘‡ğ‘¥ğ‘¦ğ‘§ for ğ‘¥ = 1
and ğ‘§ up to 4. We confirmed that our scheme for calculating ğ‘‡ğ‘¥ğ‘¦ğ‘§ produces the same results as their example
formulas for arbitrary values of ğ‘â„ and ğ‘‘â„ .
2.3 Likelihood model

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

We sought to use our data to simultaneously estimate the 3 parameters (ğ‘ğ‘ , ğ‘â„ , ğ‘‘â„ ) using maximum likelihood
estimation (MLE). However, applying the ğ‘€ğ‘˜ğ‘› formula directly to our data would be problematic because the true
number of infections ğ‘˜ in each household are not known with certainty. The data include two sources of COVID-19
test information by which prior infection status of a portion of individual household members can be
probabilistically inferred: antibody test results and surveys in which participants could report results of a priortest.
Antibody test results are subject to imperfect sensitivity and specificity due to false negative tests and false positive
tests, respectively. To account for these, we added two additional parameters to be estimated by the MLE: ğœ™ğ´ , the
probability that an antibody-tested person with a prior infection tested positive for antibodies, and ğœ‹ğ´ , the probability
that an antibody-tested person with no prior infection tested negative for antibodies.
Prior test results for SARS-CoV-2 reported on the survey also do not perfectly identify those with prior infections.
To quantify this imperfection, we introduced two more parameters to be estimated by the MLE: ğœ™ğ‘‰ , the probability
that a surveyed person with a prior infection reported receiving a positive test for the virus, and ğœ‹ğ‘‰ , the probability
that a surveyed person with no prior infection did not report receiving a positive test.
Some household members received a survey but no antibody test and other members received neither. The ğ‘€ğ‘˜ğ‘›
formula depends on the total household size ğ‘›, which for many households includes individuals with missing data.
For households with at least one but not all members infected (1 â‰¤ ğ‘˜ â‰¤ ğ‘› âˆ’ 1) and in which less than ğ‘› member
were full participants, the likelihood formula required the probability that different portions of the ğ‘˜ infected
members were among those who were antibody tested or surveyed only. To arrive at our formula, we assumed that
the antibody-tested and surveyed-only portion of a household were a random sample of household members with
respect to their prior infection status. I.e., we assumed that those individuals in a participating household with and
without prior infections were equally likely to participate in the study and equally likely to agree to antibody testing.
In all we have 7 variables to be estimated by MLE, encapsulated in the following vector ğ›‰:
ğ›‰ = (ğ‘ğ‘ , ğ‘â„ , ğ‘‘â„ , ğœ™ğ‘‰ , ğœ™ğ´ , ğœ‹ğ‘‰ , ğœ‹ğ´ )
The log likelihood of the dataset ğ² described in Section 2.1 with variable set ğ›‰ is then
ln â„’(ğ²|ğ›‰) = ğ‘“1 ln â„’(ğ²1 |ğ›‰) + â‹¯ + ğ‘“ğ¶ ln â„’(ğ²ğ¶ |ğ›‰)

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

To present the formula for â„’(ğ²ğ‘– |ğ›‰), the likelihood of a particular ğ²ğ‘– , we first define the following quantities
calculated from the core elements of ğ²ğ‘– listed in Section 2.1:
â€¢

ğ‘ğ‘ğ‘ğ‘– = ğ‘ğ‘– âˆ’ ğ‘ğ‘ƒğ‘ƒğ‘– âˆ’ ğ‘ğ‘ƒğ‘ğ‘– âˆ’ ğ‘ğ‘ğ‘ƒğ‘– : number who reported no prior positive test result and received a negative
antibody test

â€¢

ğ‘ ğ‘ğ‘– = ğ‘ ğ‘– âˆ’ ğ‘ ğ‘ƒğ‘– : number who were surveyed, reported no prior positive test result, and did not receive an
antibody test

â€¢

ğ‘ğ‘– = ğ‘›ğ‘– âˆ’ ğ‘ğ‘– âˆ’ ğ‘ ğ‘– : number untested for antibodies and not surveyed

Then we have:
ğ‘ğ‘ƒğ‘ƒğ‘– ğ‘ğ‘ƒğ‘ğ‘– ğ‘ğ‘ğ‘ƒğ‘– ğ‘ğ‘ğ‘ğ‘–

ğ‘ ğ‘ƒğ‘– ğ‘ ğ‘ğ‘–

â„’(ğ²ğ‘– |ğ›‰) = âˆ‘ âˆ‘ âˆ‘ âˆ‘ ğ´(ğ‘¢, ğ‘£, ğ‘¤, ğ‘¥; ğœ™ğ‘‰ , ğœ™ğ´ , ğœ‹ğ‘‰ , ğœ‹ğ´ ) âˆ‘ âˆ‘ ğ‘†(ğ‘¦, ğ‘§; ğœ™ğ‘‰ , ğœ‹ğ‘‰ )
ğ‘¢=0 ğ‘£=0 ğ‘¤=0 ğ‘¥=0

ğ‘¦=0 ğ‘§=0

ğ‘¢+ğ‘£+ğ‘¤+ğ‘¥+ğ‘¦+ğ‘§+ğ‘ğ‘–

âˆ‘

ğ»(ğ‘˜, ğ‘¢ + ğ‘£ + ğ‘¤ + ğ‘¥, ğ‘¦ + ğ‘§)ğ‘€ğ‘˜ğ‘›ğ‘– (ğ‘ğ‘ , ğ‘â„ , ğ‘‘â„ )

ğ‘˜=ğ‘¢+ğ‘£+ğ‘¤+ğ‘¥+ğ‘¦+ğ‘§

In the formula, the function ğ´ quantifies the probability of observing the given set of test result combinations among
antibody-tested people (ğ‘ğ‘ƒğ‘ƒğ‘– , ğ‘ğ‘ƒğ‘ğ‘– , ğ‘ğ‘ğ‘ƒğ‘– , ğ‘ğ‘ğ‘ğ‘– ), given that (ğ‘¢, ğ‘£, ğ‘¤, ğ‘¥) of them had a prior infection, respectively.
E.g., ğ‘¢ is the number of the ğ‘ğ‘ƒğ‘ƒğ‘– household member who had an infection (true positives), ğ‘£ is the number of the
ğ‘ğ‘ƒğ‘ğ‘– household members who had an infection (true positive by prior test and false negative by antibody test), ğ‘¤ is
the number of the ğ‘ğ‘ğ‘ƒğ‘– household members who had an infection (true positive by antibody test and did not report a
prior positive test), and ğ‘¥ is the number of the ğ‘ğ‘ğ‘ğ‘– household members who had an infection (false negative by
antibody test and did not report a prior positive test). The formula for ğ´ is
ğ´(ğ‘¢, ğ‘£, ğ‘¤, ğ‘¥; ğœ™ğ‘‰ , ğœ™ğ´ , ğœ‹ğ‘‰ , ğœ‹ğ´ ) = ğ‘“ğ‘š (ğ‘¢, ğ‘£, ğ‘¤, ğ‘¥; ğ©I (ğœ™ğ‘‰ , ğœ™ğ´ ))ğ‘“ğ‘š (ğ‘ğ‘ƒğ‘ƒğ‘– âˆ’ ğ‘¢, ğ‘ğ‘ƒğ‘ğ‘– âˆ’ ğ‘£, ğ‘ğ‘ğ‘ƒğ‘– âˆ’ ğ‘¤, ğ‘ğ‘ğ‘ğ‘– âˆ’ ğ‘¥; ğ©U (ğœ‹ğ‘‰ , ğœ‹ğ´ ))
The function ğ‘“ğ‘š (ğ«; ğ©) is the probability mass function for the multinomial distribution, where the number of trials is
the sum of the elements of ğ«, which are the number of infected or uninfected antibody-tested people who received
each of the four possible test result combinations. The vector ğ© contains the probability of each of the four test result
combinations given that the person was infected (for ğ© = ğ©I ) or uninfected (for ğ© = ğ©U ):
ğ©I (ğœ™ğ‘‰ , ğœ™ğ´ ) = (ğœ™ğ‘‰ ğœ™ğ´ , ğœ™ğ‘‰ (1 âˆ’ ğœ™ğ´ ), (1 âˆ’ ğœ™ğ‘‰ )ğœ™ğ´ , (1 âˆ’ ğœ™ğ‘‰ )(1 âˆ’ ğœ™ğ´ ))
ğ©U (ğœ‹ğ‘‰ , ğœ‹ğ´ ) = ((1 âˆ’ ğœ‹ğ‘‰ )(1 âˆ’ ğœ‹ğ´ ), (1 âˆ’ ğœ‹ğ‘‰ )ğœ‹ğ´ , ğœ‹ğ‘‰ (1 âˆ’ ğœ‹ğ´ ), ğœ‹ğ‘‰ ğœ‹ğ´ )

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

The first element of ğ©I , ğœ™ğ‘‰ ğœ™ğ´ , is the probability that an antibody-tested person with a prior infection reported a prior
positive test (with probability ğœ™ğ‘‰ ) and also had a positive antibody test result (with probability ğœ™ğ´ ). Note that ğœ™ğ´
represents the sensitivity of the antibody test, but ğœ™ğ‘‰ includes both the sensitivity of the prior test and the probability
that an infected person actually sought and received a SARS-CoV-2 test during the period of infection in which
detectable virus was present and reported that positive test on our survey. Elements 2â€“4 of ğ©I are the probabilities
that an antibody-tested, prior infected person reported a prior positive test but tested negative for antibodies, did not
report a prior positive test and tested positive for antibodies, and did not report a prior positive test and tested
negative for antibodies, respectively. The elements of ğ©U are the corresponding probabilities for individuals with no
prior infection.
The function ğ‘† quantifies the probability of the survey-only data (ğ‘ ğ‘ƒğ‘– , ğ‘ ğ‘ğ‘– ) given that ğ‘¦ of the ğ‘ ğ‘ƒğ‘– individuals had a
prior infection and ğ‘§ of the ğ‘ ğ‘ğ‘– individuals had a prior infection:
ğ‘†(ğ‘¦, ğ‘§; ğœ™ğ‘‰ , ğœ‹ğ‘‰ ) = ğ‘“ğ‘ (ğ‘¦; ğ‘¦ + ğ‘§, ğœ™ğ‘‰ )ğ‘“ğ‘ (ğ‘ ğ‘ğ‘– âˆ’ ğ‘§; ğ‘ ğ‘ğ‘– âˆ’ ğ‘§ + ğ‘ ğ‘ƒğ‘– âˆ’ ğ‘¦, ğœ‹ğ‘‰ )
The function ğ‘“ğ‘ (ğ‘; ğ‘Ÿ, ğ‘) is the probability mass function for the binomial distribution, for ğ‘ successes given that
there were ğ‘Ÿ independent trials with probability ğ‘ for success of each trial.
The function ğ»(ğ‘˜, ğ‘˜ğ‘ , ğ‘˜ğ‘  ) in the likelihood equation is the probability that, when ğ‘˜ of ğ‘›ğ‘– individuals in the
household were infected, ğ‘˜ğ‘ infected individuals were among the ğ‘ğ‘– individuals antibody tested and ğ‘˜ğ‘  infected
individuals were among the ğ‘ ğ‘– individuals surveyed but not antibody tested:
ğ»(ğ‘˜, ğ‘˜ğ‘ , ğ‘˜ğ‘  ) = ğ‘“â„ (ğ‘˜ğ‘ ; ğ‘˜, ğ‘›ğ‘– âˆ’ ğ‘˜, ğ‘ğ‘– )ğ‘“â„ (ğ‘˜ğ‘  ; ğ‘˜ âˆ’ ğ‘˜ğ‘ , ğ‘›ğ‘– âˆ’ ğ‘˜ âˆ’ (ğ‘ğ‘– âˆ’ ğ‘˜ğ‘ ), ğ‘ ğ‘– )
The function ğ‘“â„ (ğ‘; ğ‘, ğ‘‘, ğ‘’) is the probability mass function of the hypergeometric distribution for the number ğ‘ of
infected people selecting to be antibody-tested or surveyed-only, given that there were ğ‘ infected people and ğ‘‘
uninfected people available for selection in the household, and ğ‘’ people were tested or surveyed-only. These terms
account for individuals in households who received neither an antibody test nor a survey, who may have included
infected individuals. Our use of the hypergeometric distribution led from our assumption that, if some members of
the household had a prior infection and others didnâ€™t, the antibody-tested / surveyed individuals were a random
sample from the household with respect to their prior infection status.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

2.4 Likelihood optimization and uncertainty
We maximized the log likelihood over the 7 unknown parameters (ğ‘ğ‘ , ğ‘â„ , ğ‘‘â„ , ğœ™ğ‘‰ , ğœ™ğ´ , ğœ‹ğ‘‰ , ğœ‹ğ´ ) using the observations
(ğ‘›, ğ‘, ğ‘ , ğ‘ğ‘ƒğ‘ƒ , ğ‘ğ‘ƒğ‘ , ğ‘ğ‘ğ‘ƒ , ğ‘ ğ‘ƒ ) for each household, to produce the MLE: ğœƒÌ‚ = (ğ‘Ì‚ğ‘ , ğ‘Ì‚ â„ , ğ‘‘Ì‚â„ , ğœ™Ì‚ğ‘‰ , ğœ™Ì‚ğ´ , ğœ‹Ì‚ğ‘‰ , ğœ‹Ì‚ğ´ ). The log
likelihood maximization was performed using the â€œoptimâ€ function in R. We derived approximate confidence
interval boundaries for an individual parameter ğœƒğ‘– using the likelihood ratio test, using the statistic
2 log(â„’(ğœƒÌ‚)â„â„’(ğœƒ)), where ğœƒ consists of ğœƒğ‘– freely varying and the other 6 elements of ğœƒ held at their optimal value.
We defined a 95% confidence interval boundary where ğœƒğ‘– produces a value for this statistic equal to the 95th
percentile of the chi-squared distribution with 1 degree of freedom. We also plotted 2-dimensional confidence
region boundaries for each of the 21 possible (ğœƒğ‘– , ğœƒğ‘— ) parameter pairs by allowing each pair to vary freely together
while holding the other 5 at their optimal values. We calculated the boundary in the (ğœƒğ‘– , ğœƒğ‘— ) parameter plane where
the likelihood ratio statistic equals the 95th percentile of the chi-squared distribution with 2 degrees of freedom. To
calculate P-values at which certain fixed parameter values could be rejected in favor of the MLE, we used the chisquared distribution with degrees of freedom equal to the number of fixed parameters.
Additionally, we developed a simulation model to produce synthetic data sets on which to test our likelihood model.
We ran the simulation for the same number of households with the same sizes and participation rates for survey and
antibody testing as in the actual data (fixed values of ğ‘›, ğ‘, and ğ‘  for each household). We randomized importations
to households and simulated transmissions using the MLE values of the three epidemiological parameters ğ‘ğ‘ , ğ‘â„ ,
and ğ‘‘â„ , randomized survey and antibody test results using the MLE sensitivity and specificity values, and
maximized the likelihood against the simulated data. We repeated this process for 500 simulated data sets and
recorded the median estimated value of each variable, for comparison against the MLE value that generated the data.
We also used the 500 sets of simulation-based estimates as a parametric bootstrap to generate 95% confidence
estimates for each variable, for comparison against the intervals generated from the likelihood ratio test.
Finally, we tested an alternate model that allows the community acquisition probability to vary by household, such
that some households may have a higher per-capita acquisition rate than others applied to each household member.
To quantify this probability in the alternate model, we employed the beta-binomial distribution for the number of
community acquisitions in a household of a given size (see Supplementary Methods).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

2.5 Household transmission variability
We quantified the implications of our household transmission variability estimates by calculating the probability of
transmission extremes, compared to those produced by the classic binomial transmission model (ğ‘‘â„ = âˆ).
Specifically, we calculated the probability that an initially infected individual transmits to no one or everyone in
households of sizes from 2 to 10. For households of size ğ‘›, the probability of no transmissions from the index
infection is ğ¹0,ğ‘›âˆ’1 (ğ‘â„ , ğ‘‘â„ ) and the probability the index person transmits directly to the entire household is
ğ¹ğ‘›âˆ’1,ğ‘›âˆ’1 (ğ‘â„ , ğ‘‘â„ ). We used our overall MLE values for ğ‘Ì‚ â„ and ğ‘‘Ì‚â„ to calculate these values for each ğ‘›, with
confidence intervals using our parametric bootstrap results. For comparison to the binomial model we applied ğ‘‘â„ =
âˆ, paired with the alternate MLE of ğ‘â„ under that constraint.
We also calculated an example of a dynamic transmission model that produces a distribution of household
transmission probabilities close to that produced by our MLE beta distribution, using the method of moments.
Specifically, if an infected personâ€™s duration of infectiousness is assumed to be fixed and transmissibility to a
housemate is modeled as a gamma distribution with shape parameter ğ‘˜, then we solve for the value ğ‘˜ that produces
the same mean and variance for the transmission probability as that of the beta distribution with mean ğ‘â„ and
dispersion ğ‘‘â„ (Supplementary Methods). We solved for ğ‘˜ using our MLE ğ‘Ì‚ â„ and ğ‘‘Ì‚â„ values, and we derived a
confidence interval for ğ‘˜ using the pairs of (ğ‘â„ , ğ‘‘â„ ) estimates from our parametric bootstrap analysis.
2.6 Within-household reproduction number
We calculated the within-household reproduction number ğ‘…â„ , defined as the expected number of household
transmissions directly from a community acquirer with all fellow household members susceptible:
ğ‘…â„ = ğ‘â„ (ğœ‡ + ğœ 2 â„ğœ‡ âˆ’ 1),
where ğœ‡ and ğœ 2 are the mean and variance of the household size distribution, and ğ‘â„ is the secondary attack rate as
determined by our MLE. This equation for ğ‘…â„ is derived as in Ball et al. [30] and detailed in the Supplementary
Material.
Additionally, we derived an alternate household reproduction number ğ‘…â„âˆ— defined as the expected total number of
transmissions in the household of an infected person who acquired infection in the community and has no initially

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

non-susceptible housemates. This differs from ğ‘…â„ in that it counts all potential downstream transmissions in the
household stemming from the index community acquirer. The formula for ğ‘…â„âˆ— , derived in the Supplementary
Material, is
ğ‘âˆ’1

ğ‘…â„âˆ— = âˆ‘
ğ‘–=1

ğ‘–

(ğ‘– + 1)â„ğ‘–+1
âˆ‘ ğ‘—ğ‘‡1ğ‘—ğ‘– (ğ‘â„ , ğ‘‘â„ ),
ğœ‡
ğ‘—=1

where â„ğ‘– is the fraction of all households that are size ğ‘–.
To investigate the implications of household transmission for population-wide transmission control, we use a
threshold condition delineating subcritical and supercritical transmission in the population. Supercritical
transmission occurs when ğ‘…ğ‘ (ğ‘…â„âˆ— + 1) > 1, where ğ‘…ğ‘ is the average number of community (non-household)
transmissions from an infected person. We derive this formula in the Supplementary Material, following Ball et al.
[30]. We estimated ğ‘…â„ , ğ‘…â„âˆ— , and the threshold value for ğ‘…ğ‘ by applying our MLE estimates of ğ‘â„ and ğ‘‘â„ to the above
formulas and their confidence intervals by applying the (ğ‘â„ , ğ‘‘â„ ) pairs from each parametric bootstrap estimate.
3. Results
3.1 Data summary
We compiled data from 9,383 households (Figure 1). Of these, we retained 9,224 (98.3%) for use in the MLE. The
159 excluded households were removed because the household size was unknown (51) or the reported household
size was less than the number of people tested or surveyed in the house (108). In the 9,224 retained households,
there were 28,321 (3.07 per household) reported household members, 13,998 (1.52 per household) people who were
both surveyed and antibody tested, and another 5,249 (0.57 per household) who were surveyed but not antibody
tested. The households in the data were located in 7 of the 29 counties in Utah; the 22 excluded counties account for
<14% of Utahâ€™s total population Supplementary Table S1.
Of the 13,998 antibody tests in the retained households, 178 (1.27%) were positive. Of those 178 people with a
positive antibody test, 58 (32.6%) reported receiving a prior positive test. Of the 19,247 people who were antibody
tested or surveyed only, 119 (0.62%) reported receiving a prior positive test. This broke down to 0.53% (75 /
13,998) for those who were antibody tested and 0.84% (44 / 5,249) for those who were surveyed but not antibody
tested. The rate of testing positive for antibodies among those reporting a prior positive test was 77.3% (58 / 75).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

The interval between the reported prior positive test date and the antibody test date did not exhibit a strong
correlation to the fraction of testing antibody positive, other than perhaps the 3 individuals reporting a very recent
(less than 1 week) positive test all testing negative for antibodies (Supplementary Table S2). The rate of survey
participants agreeing to antibody testing was lower for those who reported a prior positivetest compared to those
who did not: 63.0% (75 of 119) vs. 72.8% (13,923 of 19,128), a small but statistically significant (P < 0.01)
difference in proportion.
Of the retained households, 193 (2.1%) had at least one household member who either tested positive for antibodies
or reported a prior positive test. There were 159 households with exactly 1 positive member (by either antibody test
or reported prior test or both), 26 households with 2 positives, 6 with 3 positives, 1 with 4 positives, and 1 with 6
positives. In all, there were ğ¶ = 273 unique ğ²ğ‘– vectors representing household data described in section 2.1.
The crude secondary attack rate measure derived from antibody testing only (fraction of antibody-tested housemates
of antibody-positive household members who were also antibody positive) was 14.9% (29 / 194). The crude
secondary attack rate estimate from reported prior test data only (fraction of surveyed housemates of people
reporting a prior positive test who also reported a prior positive test) was 23.0% (31 / 135). When combining both
types of data, the crude secondary attack rate estimate (fraction of surveyed / tested housemates of any antibodypositive or reported-prior-positive person who were positive by either or both measures) was 15.6% (46 / 295).
We tallied demographic statistics of the set of surveyed individuals (Supplementary Table S3). The distribution of
reported ages skewed older than Utahâ€™s overall population age distribution, and females were slightly
overrepresented (52.0%). The distribution of surveyed individualsâ€™ race, Hispanic origin, and education level also
differed from the overall Utah and U.S. distributions.
3.2 Maximum likelihood estimates
Our MLE procedure produced simultaneous estimates for all 7 parameters (Table 1). The MLE for ğ‘ğ‘ , the perperson community acquisition probability from outside the household, was 0.41% (0.32% â€“ 0.51%). For within
household transmission probability, the MLE produced an average secondary attack rate estimate ğ‘â„ = 36% (27% â€“
48%). The MLE for the dispersion parameter ğ‘‘â„ , quantifying variability in transmissibility by person, was 0.43

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

(0.02 â€“ 2.0). The boundary case ğ‘‘â„ = âˆ, representing the classic binomial household transmission model with no
variability in individual infectiousness [27], could be rejected with P = 0.001 (Table 2).
Our MLE result for ğœ™ğ‘‰ , the probability that a surveyed person with a prior infection reported a prior positive test,
was 72% (62% â€“ 82%). The ğœ™ğ‘‰ value can be interpreted as the case ascertainment fraction, i.e. fraction of
individuals with SARS-CoV infections who were identified with a positive test during their infection. Our result
may be high compared to other areas of the U.S.: one study estimated that less than 60% of symptomatic cases in the
U.S. were identified during February-June 2020 [31]. Our finding may reflect unusually successful case
ascertainment efforts in Utah during the Spring and early Summer of 2020, perhaps partly owing to slower
emergence compared to other regions.
For ğœ‹ğ‘‰ , the probability that a surveyed person with no prior infection reported no prior positive test, the MLE was
99.94% (99.88% â€“ 99.98%). This result is consistent with the low probability of false positives among viral tests,
which to our knowledge were exclusively PCR-based in Utah prior to our data collection. It is possible that some
false positives in our survey data occurred by erroneous reporting, i.e. survey respondents reporting a prior positive
test that did not occur, rather than via errors in testing procedure. Even though our MLE for this parameter was in
excess of 99.9%, we found that an alternate model assuming ğœ‹ğ‘‰ = 100% produced notably different estimates of
some of the other parameters (Table 2), which suggests that studies producing epidemiological estimates relying on
a 100% viral test specificity assumption should test robustness of conclusions to small deviations from that
assumption. For ğœ™ğ´ , the probability that a prior-infected personâ€™s antibody test was positive, the MLE was 86%
(75% â€“ 93%), a result that is similar to the test manufacturerâ€™s finding that 109 of 122 (89%) PCR-positive subjects
were positive for antibodies [32]. However, the manufacturerâ€™s results included only symptomatic subjects and were
highly dependent on the number of days post-symptom onset at which the serological sample was taken. Because
the symptom histories of the antibody-tested people in our data are largely uncertain, it is difficult to determine how
consistent our result is with the manufacturerâ€™s data.
For ğœ‹ğ´ , the probability that an antibody-tested person with no prior infection tested negative for antibodies was
99.3% (99.2% â€“ 99.5%), which is within the uncertainty range of the test manufacturerâ€™s estimate of 99.6% (99.0%
â€“ 99.9%) based on 4 positive tests from 997 samples collected prior to September 2019 [32]. When instead
assuming the manufacturerâ€™s point specificity estimate of 99.6% directly, our estimates of the other parameters

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

changed modestly (Table 2). When we ran our MLE under the assumption of perfect specificity (no false positives)
for the antibody test (ğœ‹ğ´ = 100%), the result for secondary attack rate reduced from 36% to 18%, which is closer to
the crude estimate described in Section 3.1, and the results for community acquisition probability increased from
0.4% to 1.2% (Table 2). Thus, our model suggests that allowing for false positives can shift the attribution of
infections toward household transmissions and away from acquisitions outside the household. We also found that
assuming perfect specificity of the antibody test dramatically reduced the estimate of ğœ™ğ‘‰ from 72% to 37% (Table
2), which suggests that ignoring false positives in serology data could cause an underestimate of the case
ascertainment rate if the serology data are used for that purpose.
When optimizing the likelihood equation against 500 synthetic data sets simulated using the MLE variable
assumptions, the median estimates of each parameter were very close to the MLE values (Table 1). The confidence
intervals derived from these bootstrap estimates were similar to those derived from the likelihood ratio test, though
the bootstrap intervals were somewhat wider for the three parameters governing importation and transmission.
Likewise, the likelihood ratio-based intervals reported in Table 1 expanded modestly when we calculated 2dimensional confidence regions based on each pair of estimated parameters, with most regions exhibiting close to
symmetric shapes around the MLE (Supplemental Figures). Notably, the 95% confidence regions involving the
transmission dispersion parameter ğ‘‘â„ can extend to the high-variability boundary ğ‘‘â„ = 0, a result that is also
reflected by the fact that the MLE for the model with fixed ğ‘‘â„ = 0 cannot be rejected with high confidence (P =
0.16) (Table 2).
Our alternate model that employed a beta-binomial distribution for the number of household acquisitions, using a
new dispersion parameter ğ‘‘ğ‘ estimated as an additional variable in the MLE, found ğ‘‘ğ‘ = 2.1 (0.89 â€“ 7.5), with
somewhat altered estimates of the other parameters (Table S4) compared to those in Table 1. However, the log
likelihood of the model in Table 1, which is equivalent to the alternate model with ğ‘‘ğ‘ = âˆ, is sufficiently close to
that of the alternate model that ğ‘‘ğ‘ = âˆ cannot be rejected by the likelihood ratio test and is favored by the Bayesian
information criterion. However, if overdispersion in household community acquisitions does occur, the uncertainty
ranges of the transmission variables ğ‘â„ and ğ‘‘â„ become large (see Supplementary Results).
3.3 Household transmission variability

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

We quantified the implications of our key finding of high transmission variability within households of persons
infected with COVID-19 by calculating the probability of transmission extremes. Compared to our overall MLE, the
classic binomial transmission model (ğ‘‘â„ = âˆ) produced a similar average secondary attack rate estimate of ğ‘â„ =
32% (24% â€“ 41%). However, the binomial model produces substantially lower probabilities that an infected
individual transmits to no one or everyone in larger households (Table 3).
For example, our MLE model estimates that an infected member of an 8-member household would have a 46%
(22% â€“ 70%) chance of transmitting to no one, but a 20% (3% â€“ 50%) chance of transmitting infection directly to all
7 housemates. By contrast, the no-variability binomial model estimate would be substantially lower for each
extreme: 7% (3% â€“ 14%) chance of transmitting to no one and 0.03% (0.005% â€“ 0.2%) chance of transmitting to
everyone (Table 3).
We calculated an example of a dynamic transmission model that would produce the same mean and variance of a
personâ€™s transmission probability to a household member that is produced by our MLE beta distribution. If an
infected personâ€™s duration of infectiousness is assumed to be fixed and transmissibility to a housemate is modeled as
a gamma distribution with shape ğ‘˜, then ğ‘˜ = 0.18 (95% CI 0 â€“ 0.7) when the mean and variance are matched,
regardless of the infectious duration (Supplementary Methods). This estimate of ğ‘˜ is comparable to the dispersion
parameter ğ‘˜ of the negative binomial distribution commonly used to characterize overall variability in the number of
transmissions from individuals, which can be derived from the Poisson distribution with a mean that is gammadistributed with shape parameter ğ‘˜ [17]. Our estimate of ğ‘˜ is similar to point estimates for SARS-CoV-2 of ğ‘˜ = 0.1
[22], ğ‘˜ = 0.25 [23], and ğ‘˜ = 0.33 [24].
3.4 Within-household reproduction numbers
Our estimate of the household reproduction number ğ‘…â„ , the expected number of household transmissions from a
community acquirer with no other infected fellow household members, depends on our estimate of ğ‘â„ and the mean
ğœ‡ and variance ğœ 2 of the household size distribution. From our data we found ğœ‡ = 3.07 and ğœ 2 = 3.12, so our
estimate is ğ‘…â„ = 1.12 (0.78 â€“ 1.56). Our estimate of the alternate household reproduction number ğ‘…â„âˆ— , the expected
total number of transmissions in the household of a community acquirer, is ğ‘…â„âˆ— = 1.45 (0.94 â€“ 2.05).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

The supercritical threshold for ğ‘…ğ‘ , the average number of non-household transmissions by an infected individual, is
approximated by 1â„(ğ‘…â„âˆ— + 1) (see Methods section 2.6 and Supplementary Material). Using our estimate for ğ‘…â„âˆ— in
Utah, this formula suggests that ğ‘…ğ‘ must be kept below approximately 0.41 (0.33 â€“ 0.52) to avoid increasing growth
of COVID-19 infections in the population.
4. Discussion
The key findings of our analyses stem from our simultaneous estimation of the average and variability of SARSCoV-2 household transmission, household importation, and test data accuracy. Our novel combination of those
interacting features within our model revealed two important epidemiological insights. First, we found that
accounting for test error, especially the specificity of the serological antibody test, produced a substantially higher
estimate for the household secondary attack rate. Second, we found evidence of substantial variability of
transmissibility within households, which has important implications for understanding broad transmission patterns
and mitigation strategies.
An important implication of the first finding is that assuming perfect test accuracy may be a source of
underestimation for the household secondary attack rate in other studies. Our maximum likelihood estimate was
35% (27% â€“ 48%), which is higher than recent pooled estimates of 17â€“19% from the most recent meta-analyses of
worldwide household studies [7, 8]. These and other published studies have generally estimated the secondary attack
rate by a simple calculation of the fraction of tests that were positive among household contacts of known cases.
When we applied that calculation to our combined data, we found a crude secondary attack rate estimate of 15.6%.
We traced the major source of this substantial underestimate to the assumption of perfect test specificity inherent in
the crude formula.
[32]Our second major finding of overdispersion of household transmission stemmed from our use of the betabinomial distribution to quantify the number of household transmissions from infected individuals. We quantified
individual-level variability in transmissibility using a dispersion parameter ğ‘‘â„ , and the optimal value occurred at low
dispersion (high variability; ğ‘‘â„ = 0.43). The more commonly used binomial model, a special case of our model at
minimal variability (ğ‘‘â„ â†’ âˆ), was rejected, suggesting that transmission patterns are not well captured by that
simplifying assumption.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Our dispersion parameter estimate is not directly comparable to another commonly used dispersion parameter, often
named ğ‘˜, that characterizes variability in the total number of transmissions (whether household or not) from each
infected person as a parameter of the negative binomial distribution [17]. We converted ğ‘‘â„ to ğ‘˜ in the context of
simple model in which the only source of variability is a personâ€™s transmissibility per unit time in contact with
others, finding ğ‘˜ = 0.18, similar to other published results for SARS-CoV-2. This similarity perhaps suggests that
variability in infectivity per time is a major driver of overall transmission variability for SARS-CoV-2. This could
be consistent with findings that viral shedding is highly variable by individuals with SARS-CoV-2 infections, both
during asymptomatic and symptomatic phases of disease, suggesting that heterogeneous transmissibility may be
largely explained by overdispersion in levels of viral shedding by individuals [33]. However, other studies suggest
that SARS-CoV-2 transmission overdispersion in the wider population beyond households may be less driven by
biological heterogeneity and more by heterogeneous social contact behavior [34].
The level of within-household transmission variability captured by the parameter ğ‘‘â„ affects the contribution of
household transmission toward threshold levels of overall transmission. Threshold conditions are often expressed
using a reproduction number (ğ‘…), the average number of transmissions from each infected person. The average
number of household transmissions directly from an initially infected household member (ğ‘…â„ ) is independent of ğ‘‘â„ ,
but ğ‘‘â„ does affect the average number of household transmissions in the next generation, i.e. by someone who
acquired infection from a housemate. When transmission variability is higher, the household transmission potential
of a household acquirer is lower, reducing to zero in the â€œall-or-nothingâ€ limit ğ‘‘â„ = 0. To capture this effect, we
introduced an alternate reproduction number ğ‘…â„âˆ— , which is the average number of total household transmissions after
the initial introduction, when final household outbreak size has been reached.
Neither ğ‘…â„ > 1 nor ğ‘…â„âˆ— > 1 are sufficient threshold conditions for sustained transmission in a community, which
requires some level of between-household transmission to be maintained. Given our estimate of ğ‘…â„âˆ— = 1.45 (0.94 â€“
2.05), we can estimate the critical value of ğ‘…ğ‘ , the average number of non-household community transmission that
would push transmission for the population above the supercritical threshold for a growing epidemic, with the
threshold condition ğ‘…ğ‘ > 1â„(ğ‘…â„âˆ— + 1). Thus, we estimate that ğ‘…ğ‘ must be kept below approximately 0.41 (0.33 â€“
0.52) to avoid continued case growth in Utah if household transmission continues to be well characterized by our
model. As this result depended on the average household size in our data, it is notable that Utah has the highest

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

state-average household size in the United States. The average household size in Utah is 3.1, about 20% higher than
the national average household size. Thus, our ğ‘…â„ estimate may be high compared to other locations. A lower value
of ğ‘…â„ would lead to a higher threshold value for ğ‘…ğ‘ .The potential contribution of interventions to reduce household
transmission may also be important. Using the terms defined above, if ğ‘…ğ‘ < 1 but ğ‘…ğ‘ (ğ‘…â„âˆ— + 1) > 1, then overall
transmission is above-threshold but could be pushed below-threshold by reducing household transmission alone,
such that ğ‘…â„âˆ— < 1â„ğ‘…ğ‘ âˆ’ 1. Methods to reduce household transmission might include increased used of at-home
testing to earlier detect potential asymptomatic or pre-symptomatic transmitters, paired with increased use of masks,
disinfectants, and/or distancing within homes of an infectious person [35]. [32][31]
This study has several limitations. Our estimate of high household transmission variability may not be robust to
alternate assumptions for the way community acquisition risk varies by household. For example, some households
could have been comprised of families with both parents working essential jobs during Spring/Summer 2020, with
children attending in-person day care or camps, thus placing the entire household at much higher risk of community
acquisition compared to households working / caring for children at home. Also, households could have high
collective community acquisition probability via attending multi-household gatherings of extended family or other
social groups. In these ways, households conceivably could vary considerably in their infection numbers for reasons
that donâ€™t involve within-household transmission.
We tested the implications of this alternate possibility for household variability in our model by allowing variability
in community acquisition by household using an additional dispersion parameter to the MLE model (Supplementary
Results). Interestingly, the MLE for the transmission dispersion parameter ğ‘‘â„ still occurred at high variability in
household transmission (ğ‘‘Ì‚â„ = 0.21) under this alternate model. Furthermore, the improvement in likelihood was not
substantial, such that the more complicated model would not be favored by the likelihood ratio test nor the Bayesian
information criterion. However, larger uncertainty ranges under the alternate model suggest that we may not be able
to definitively rule out the possibility that variability in community acquisition risk by household plays a substantial
role in explaining overall variability in household infection numbers.
It is also possible that household transmission variability could be driven by properties of households such as contact
behavior, underlying health composition of household members, physical properties of the domicile such as size and
ventilation, or other properties that could increase transmission risk of all household members together. Possible

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

variability in person-to-person transmission probability by household, rather than by individual, is not accounted for
in our model. Using a beta distribution for this probability across different households to arrive at an alternate final
size distribution would require integrating the beta distribution over the full final size distribution equations
produced by the binomial-chain model, which would be complicated for larger households. Alternatively, one could
model a functional relationship between observed properties of a household in the dataset and its average
transmission probability, while retaining dispersion occurring at the individual level. We have not attempted this
with our data; we suspect that the sample size of outbreaks in households with a given feature would not be large
enough to draw meaningful conclusions, but this could be an important direction of future work enhanced by a
larger dataset.
Another limitation lies in our potentially inaccurate assumptions used to quantify the probability of prior infections
among those with missing data within participating households. Most non-participating individuals within
participating households were children under 12, who were not offered antibody tests. Older participants could fill
out surveys on behalf of children of any age, including reporting of prior positive tests, but participation in that
option was low. Thus, our assumption that non-participants had equal community acquisition rates, susceptibility to
acquisition from another household member, and transmissibility to other household members compared to study
participants would be violated if children were substantially different from adults in one or more of those quantities.
Our assumption is consistent with studies finding similar transmission rates to and from children compared to adults.
In a study of COVID-19 clusters linked to day care centers within our study area in Utah [36], 42% of the cases
occurred in children, who represented 60% of the people with epidemiological contacts to the facilities. The infected
children (median age 7) transmitted infection to at least 26% of their non-facility contacts, close to our household
estimate. Another study found that children under 10 in China were as likely to be infected as adults [37]. However,
other studies suggest that children may be less likely to acquire infection than adults [38], and one study found very
low household secondary attack from infected children in South Korea [39]. A study similar to ours found lower
rates of importation and household acquisition among children aged 5-9 compared to older groups, although
confidence intervals overlapped [15]. If substantial differences existed between children under 12 and our study
participants, one or more of our estimates could be biased.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

In addition, many eligible participants older than 12 chose not to participate, either declining the serological
antibody test only (but still filling out a survey) or declining to participate at all. Comparing full participants to
survey-only participants, we found that participants reporting a prior positive SARS-CoV-2 test were less likely to
agree to antibody testing, though the difference was not large (63.0% vs. 72.8%). It is unknown whether a prior
confirmed or suspected infection affected eligible household membersâ€™ decision to agree or decline to fill out a
survey. The full set of surveyed participants had different distributions of reported age, sex, race, Hispanic origin,
and education level compared to the wider population, and future work could assess the implications of those
differences for extrapolating COVID-19 risk to other households.
We also have not adjusted for potential biases related to non-participation rates of entire households that were
selected and approached for inclusion in the study. Our data collection included a complicated sampling design
across several different strata, and weights were introduced partly to account for different rates of nonresponse
across the different strata. For simplicity we ignored these details and sampling weights for the analysis presented
here. Also, while the 7 included Utah counties represent >86% of the state population, there may be important
differences in households from the 22 excluded counties. Thus, households with higher COVID-19 risk may be
overrepresented or underrepresented in our data relative to their frequency in the broader population of households
in Utah.
Although these potential limitations, which also exist for other analyses of household transmission from serological
data [13-15], remain in our analysis, we believe our model has addressed other limitations of existing models that
may be more substantial. Our improvements to household secondary attack rate estimates, including factoring out
non-household community acquisitions and tertiary transmissions, inclusion of overdispersion estimates, and careful
consideration of the impact of imperfect test sensitivity and specificity, have produced improved insights into this
important measure. While the likelihood equations resulting from our model are somewhat complicated, we have
provided full mathematical specification and computational code for reproducibility. The ability to explicitly
calculate the likelihood for our model is an advantage for optimization speed and further mathematical analysis, and
extensions to the epidemiological household model can readily be simulated to explore potential improvements.
In conclusion, we found evidence of a relatively high secondary attack rate and high overdispersion in transmission
of SARS-COV-2 in Utah households during a time when overall community prevalence was low. Other published

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

household secondary attack rates may be underestimated without accounting for imperfect test sensitivity and
specificity. Controllability of the virus may depend on mitigating transmission from a minority of highly infectious
individuals in large households and other household-like locations where several people congregate indoors for
extended periods.

References

1.
2.
3.
4.

5.
6.
7.
8.
9.

10.
11.

12.

13.

14.
15.

Leclerc QJ, Fuller NM, Knight LE, Group CC-W, Funk S, Knight GM. What settings have been
linked to SARS-CoV-2 transmission clusters? Wellcome Open Res 2020; 5: 83.
Nishiura H, Oshitani H, Kobayashi T, et al. Closed environments facilitate secondary transmission
of coranvirus disease 2019 (COVID-19). MedRxiv 2020; 2020.02.28.20029272.
Qian H, Miao T, Liu L, Zheng X, Luo D, Li Y. Indoor transmission of SARS-CoV-2. Indoor Air 2020;
ina.12766.
Badr HS, Du H, Marshall M, Dong E, Squire MM, Gardner LM. Association between mobility
patterns and COVID-19 transmission in the USA: a mathematical modelling study. Lancet Infect
Dis 2020; 20(11): 1247-54.
Zhu Y, Wang C, Dong L, Xiao M. Home quarantine or centralized quarantine, which is more
conducive to fighting COVID-19 pandemic? Brain Behav Immun 2020; 87: 142-3.
Lei H, Xu X, Xiao S, Wu X, Shu Y. Household transmission of COVID-19-a systematic review and
meta-analysis. J Infect 2020; 81(6): 979-97.
Fung HF, Martinez L, Alarid-Escudero F, et al. The household secondary attack rate of SARS-CoV2: A rapid review. Clin Infect Dis 2020; ciaa1558.
Madewell ZJ, Yang Y, Longini IM, Halloran ME, Dean NE. Household transmission of SARS-CoV-2:
a systematic review and meta-analysis. JAMA Netw Open 2020; 3(12): e2031756.
Yousaf AR, Duca LM, Chu V, et al. A prospective cohort study in non-hospitalized household
contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time. Clin
Infect Dis 2020; ciaa1072.
Dawson P, Rabold EM, Laws RL, et al. Loss of Taste and Smell as Distinguishing Symptoms of
COVID-19. Clin Infect Dis 2020; ciaa799.
Rosenberg ES, Dufort EM, Blog DS, et al. COVID-19 Testing, Epidemic Features, Hospital
Outcomes, and Household Prevalence, New York State-March 2020. Clin Infect Dis 2020; 71(8):
1953-9.
Grijalva CG, Rolfes MA, Zhu Y, et al. Transmission of SARS-COV-2 Infections in Households Tennessee and Wisconsin, April-September 2020. MMWR Morb Mortal Wkly Rep 2020; 69(44):
1631-4.
Pollan M, Perez-Gomez B, Pastor-Barriuso R, et al. Prevalence of SARS-CoV-2 in Spain (ENECOVID): a nationwide, population-based seroepidemiological study. Lancet 2020; 396(10250):
535-44.
Silveira MF, Barros AJD, Horta BL, et al. Population-based surveys of antibodies against SARSCoV-2 in Southern Brazil. Nat Med 2020; 26(8): 1196-9.
Bi Q, Lessler J, Eckerle I, et al. Household Transmission of SARS-COV-2: Insights from a
Population-based Serological Survey. MedRxiv 2020; 2020.11.04.20225573.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

16.
17.
18.
19.

20.
21.
22.

23.
24.
25.
26.

27.
28.
29.
30.
31.
32.
33.
34.
35.

36.

Gomes MGM, Corder RM, King JG, et al. Individual variation in susceptibility or exposure to
SARS-CoV-2 lowers the herd immunity threshold. medRxiv 2020; 2020.04.27.20081893.
Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual
variation on disease emergence. Nature 2005; 438(7066): 355-9.
Frieden TR, Lee CT. Identifying and Interrupting Superspreading Events-Implications for Control
of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis 2020; 26(6): 1059-66.
Endo A, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group,
Leclerc QJ, et al. Implication of backward contact tracing in the presence of overdispersed
transmission in COVID-19 outbreaks [version 1; peer review: 2 approved]. Wellcome Open Res
2020; 5(239).
Liu Y, Eggo RM, Kucharski AJ. Secondary attack rate and superspreading events for SARS-CoV-2.
Lancet 2020; 395(10227): e47.
Kain MP, Childs ML, Becker AD, Mordecai EA. Chopping the tail: how preventing superspreading
can help to maintain COVID-19 control. Epidemics 2021; 34: 100430.
Endo A, Centre for the Mathematical Modelling of Infectious Diseases C-WG, Abbott S, Kucharski
AJ, Funk S. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside
China. Wellcome Open Res 2020; 5: 67.
Zhang Y, Li Y, Wang L, Li M, Zhou X. Evaluating Transmission Heterogeneity and Super-Spreading
Event of COVID-19 in a Metropolis of China. Int J Environ Res Public Health 2020; 17(10).
Adam DC, Wu P, Wong JY, et al. Clustering and superspreading potential of SARS-CoV-2
infections in Hong Kong. Nat Med 2020; 26(11): 1714-9.
Wong F, Collins JJ. Evidence that coronavirus superspreading is fat-tailed. Proc Natl Acad Sci U S
A 2020; 117(47): 29416-8.
Wang L, Didelot X, Yang J, et al. Inference of person-to-person transmission of COVID-19 reveals
hidden super-spreading events during the early outbreak phase. Nat Commun 2020; 11(1):
5006.
Longini I, Koopman JS. Household and community transmission parameters from final
distributions of infections in households. Biometrics 1982; 38(1): 115-26.
Samore M, Looney A, Orleans B, et al. SARS-CoV-2 seroprevalence and detection fraction in Utah
urban populations from a probability-based sample. MedRxiv 2020; 2020.10.26.20219907.
Becker N. An epidemic chain model. Biometrics 1980; 36(2): 249-54.
Ball F, Mollison D, Scalia-Tomba G. Epidemics with two levels of mixing. The Annals of Applied
Probability 1997; 7(1): 46-89.
Russell TW, Golding N, Hellewell J, et al. Reconstructing the early global dynamics of underascertained COVID-19 cases and infections. BMC Med 2020; 18(1): 332.
SARS-CoV-2 IgG Architect - Instructions for Use. Available at:
https://www.fda.gov/media/137383/download. Accessed 1/25/2021.
Chen PZ, Bobrovitz N, Premji Z, Koopmans M, Fisman DN, Gu FX. Heterogeneity in
transmissibility and shedding SARS-CoV-2 via droplets and aerosols. Elife 2021; 10.
Susswein Z, Bansal S. Characterizing superspreading of SARS-CoV-2: from mechanism to
measurement. medRxiv 2020; 2020.12.08.20246082.
Wang Y, Tian H, Zhang L, et al. Reduction of secondary transmission of SARS-CoV-2 in
households by face mask use, disinfection and social distancing: a cohort study in Beijing, China.
BMJ Glob Health 2020; 5(5).
Lopez AS, Hill M, Antezano J, et al. Transmission Dynamics of COVID-19 Outbreaks Associated
with Child Care Facilities - Salt Lake City, Utah, April-July 2020. MMWR Morb Mortal Wkly Rep
2020; 69(37): 1319-23.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

37.

38.
39.

Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of
their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020;
20(8): 911-9.
Li X, Xu W, Dozier M, et al. The role of children in transmission of SARS-CoV-2: A rapid review. J
Glob Health 2020; 10(1): 011101.
Kim J, Choe YJ, Lee J, et al. Role of children in household transmission of COVID-19. Arch Dis
Child 2020; archdischild-2020-319910.

Figure 1. Data summary flowchart.

Flow diagram for data from participating households and household members

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Table 1. Maximum likelihood estimates
Value

MLE (95% CI)

Parametric bootstrap:
median (95% range)

Mean community acquisition probability (ğ‘ğ‘ )

0.41% (0.32% â€“ 0.51%)

0.41% (0.30% â€“ 0.55%)

Mean per-capita household transmission probability (ğ‘â„ )

36% (27% â€“ 48%)

36% (25% â€“ 51%)

Per-capita household transmission dispersion (ğ‘‘â„ )

0.43 (0.02 â€“ 2.0)

0.38 (0 â€“ 2.2)

Probability infected person reported a prior positive test (ğœ™ğ‘‰ )

72% (62% â€“ 82%)

72% (63% â€“ 82%)

Probability infected person tested positive for antibodies (ğœ™ğ´ )

86% (75% â€“ 93%)

86% (77% â€“ 95%)

Probability uninfected person did not report a prior positive test (ğœ‹ğ‘‰ )

99.94% (99.88% â€“ 99.98%)

99.94% (99.87% â€“ 99.99%)

Probability uninfected person tested negative for antibodies (ğœ‹ğ´ )

99.3% (99.2% â€“ 99.5%)

99.3% (99.2% â€“ 99.5%)

Confidence intervals for MLE derived from the likelihood ratio test, varying each individual parameter while fixing other parameters at their
MLE values. Parametric bootstrap was based on MLE fits to 500 different synthetic data sets generated from stochastic simulations using the
MLE parameter values.

Table 2. Comparison of MLE for alternate models
Fixed values

ğ‘Ì‚ğ‘

ğ‘‘Ì‚â„

ğ‘Ì‚â„

ğœ™Ì‚ğ‘‰

ğœ™Ì‚ğ´

ğœ‹Ì‚ğ‘‰

ğœ‹Ì‚ğ´

Log

Rejection

likelihood

P value

None

0.408%

36.3%

0.434

72.4%

85.6%

99.94%

99.3%

âˆ’1173.84

-

ğ‘‘â„ = 0

0.443%

41.3%

0*

68.4%

80.3%

99.95%

99.3%

âˆ’1174.85

0.16

ğ‘‘â„ = âˆ

0.340%

31.9%

âˆ*

75.6%

89.0%

99.91%

99.3%

âˆ’1179.30

0.00096

ğœ‹ğ‘£ = 100%

0.508%

33.7%

0.161

69.9%

76.9%

100%*

99.3%

âˆ’1176.01

0.037

ğœ‹ğ‘ = 99.6%

0.569%

30.7%

0.208

59.9%

82.7%

99.96%

99.6%*

âˆ’1181.08

0.00014

ğœ‹ğ‘ = 100%

1.24%

17.6%

0.0217

36.6%

78.4%

100%

100%*

âˆ’1201.26

<0.0001

*Values that were fixed for the model in that row; other values were optimized by MLE. P values were derived from the likelihood ratio test,
compared to the likelihood of the overall MLE in the top row (twice the difference in log likelihood compared to the chi-squared distribution with
one degree of freedom).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Table 3. Effect of transmission overdispersion on probability that first infected person transmits to no one or
everyone in the household
Household

Transmit to none: overall

Transmit to none: binomial

Transmit to all: overall

Transmit to all: binomial

size

model MLE (95% CI)

model MLE (95% CI)

model MLE (95% CI)

model MLE (95% CI)

2

64% (49% â€“ 75%)

68% (59% â€“ 76%)

36% (25% â€“ 51%)

32% (24% â€“ 41%)

3

57% (42% â€“ 71%)

46% (35% â€“ 57%)

29% (14% â€“ 49%)

10% (6% â€“ 17%)

4

53% (34% â€“ 69%)

32% (21% â€“ 43%)

26% (9% â€“ 49%)

3% (1% â€“ 7%)

5

51% (30% â€“ 69%)

22% (12% â€“ 33%)

24% (6% â€“ 50%)

1% (0.3% â€“ 3%)

6

49% (26% â€“ 69%)

15% (7% â€“ 25%)

22% (5% â€“ 50%)

0.3% (0.08% â€“ 1%)

7

47% (24% â€“ 69%)

10% (4% â€“ 19%)

21% (3% â€“ 50%)

0.1% (0.02% â€“ 0.5%)

8

46% (22% â€“ 70%)

7% (3% â€“ 14%)

20% (3% â€“ 50%)

0.03% (0.005% â€“ 0.2%)

9

45% (20% â€“ 70%)

5% (2% â€“ 11%)

20% (2% â€“ 50%)

0.01% (0.001% â€“ 0.08%)

10

44% (19% â€“ 70%)

3% (0.9% â€“ 8%)

19% (2% â€“ 51%)

0.003% (0.0003% â€“ 0.03%)

Probabilities in this table are for a single infected household member transmitting directly to no one or everyone else in the household. The
â€œtransmit to allâ€ values do not include the probability of multiple-generation transmission chains that eventually infect all household members.
Confidence intervals for the overall MLE-based estimates were derived from applying (ğ‘â„ , ğ‘‘â„ ) pairs from our parametric bootstrap analysis to the
beta-binomial transmission equations.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Supplementary material for â€œHigh variability in transmission of SARS-CoV-2 within households and
implications for control,â€ authored by Damon J.A. Toth et al.
Supplemental Methods
Survey data
Answers to the following questions for individual household members were used in our analysis:
1) â€œHave you ever been tested for coronavirus (also called SARS-CoV-2 or COVID-19)?â€ (Yes or No)
If the answer to 1) was Yes, the following two questions were asked:
2) What was the result? (Positive; Negative; Have not received test result; or Donâ€™t know)
3) When were you tested? (MM/DD/YYYY)
All individuals who answered â€œYesâ€ to question 1 and â€œPositiveâ€ to question 2 were classified as â€œreported a prior
positive test,â€ and all other surveyed individuals were classified as â€œdid not report a prior positive test,â€ as described
in the main text. For individuals who reported a prior positive test and also received an antibody test, we used the
answer to question 3, compared to the collection date of serology, to construct Table S2.
Alternate model with variability in household importation
For the alternate model, the formula for ğ‘€ğ‘˜ğ‘› for a given household size ğ‘› â‰¥ 2 becomes
ğ¹0ğ‘› (ğ‘ğ‘ , ğ‘‘ğ‘ ),

ğ‘˜=0

ğ‘˜

ğ‘€ğ‘˜ğ‘› (ğ‘ğ‘ , ğ‘‘ğ‘ , ğ‘â„ , ğ‘‘â„ ) =

âˆ‘ ğ¹ğ‘–ğ‘› (ğ‘ğ‘ , ğ‘‘ğ‘ )ğ‘‡ğ‘–,ğ‘˜âˆ’ğ‘–,ğ‘›âˆ’ğ‘– (ğ‘â„ , ğ‘‘â„ ) , ğ‘˜ = 1, â€¦ , ğ‘› âˆ’ 1
ğ‘–=1
ğ‘›âˆ’1

{

1 âˆ’ âˆ‘ ğ‘€ğ‘˜ğ‘› (ğ‘ğ‘ , ğ‘‘ğ‘ , ğ‘â„ , ğ‘‘â„ ) ,

ğ‘˜=ğ‘›

ğ‘˜=0

For households of size ğ‘› = 1, ğ‘€01 (ğ‘ğ‘ , ğ‘‘ğ‘ ) = ğ¹01 (ğ‘ğ‘ , ğ‘‘ğ‘ ) and ğ‘€11 (ğ‘ğ‘ , ğ‘‘ğ‘ , ) = 1 âˆ’ ğ¹01 (ğ‘ğ‘ , ğ‘‘ğ‘ ). The function
ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) is defined in the main text (probability mass function of the beta-binomial distribution with boundary case
definitions at ğ‘‘ = 0 and ğ‘‘ â†’ âˆ), where in this case ğ‘¦ is the number of community acquisitions and ğ‘§ is the total
number of household members. The main-text model is a special case of this alternate model, with ğ‘‘ğ‘ â†’ âˆ.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

The likelihood equation is the same as in the main text, but with the additional element ğ‘‘ğ‘ in the vector ğ›‰ of
variables to be optimized:
ğ›‰ = (ğ‘ğ‘ , ğ‘‘ğ‘ , ğ‘â„ , ğ‘‘â„ , ğœ™ğ‘‰ , ğœ™ğ´ , ğœ‹ğ‘‰ , ğœ‹ğ´ )
and ğ‘€ğ‘˜ğ‘› (ğ‘ğ‘ , ğ‘â„ , ğ‘‘â„ ) in the likelihood equation is replaced with ğ‘€ğ‘˜ğ‘› (ğ‘ğ‘ , ğ‘‘ğ‘ , ğ‘â„ , ğ‘‘â„ ) as defined above.
We found the MLE and single-parameter confidence intervals using the same procedure described in the main text,
and further assessed uncertainty of ğ‘‘â„ by solving for the MLE of the other 7 variables when fixing it at its boundary
values 0 and âˆ. We also compared the likelihood at the MLE of the alternate model to that of the main text model
using the likelihood ratio test, to determine whether the main text model result could be rejected in favor of the
alternate model by this criterion. As an additional comparison, we used the Bayesian information criterion to score
the alternate model against the main text model, using 9224 as the number of data points (number of households)
and 7 and 8 as the number of parameters for the main-text model and alternate model, respectively.
Beta-binomial distribution at limits of dispersion parameter: ğ’… â†’ âˆ and ğ’… â†’ ğŸ
Our likelihood equations make use of the beta-binomial probability distribution, parameterized with an average
probability ğ‘ and a dispersion parameter ğ‘‘. The probability mass function ğ¹ for positive, finite values of ğ‘‘ is
ğ‘§ B(ğ‘¦ + ğ‘‘ğ‘, ğ‘§ âˆ’ ğ‘¦ + ğ‘‘(1 âˆ’ ğ‘))
ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) = (ğ‘¦)
,
B(ğ‘‘ğ‘, ğ‘‘(1 âˆ’ ğ‘))

ğ‘¦ = 0,1, â€¦ , ğ‘§

We use ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) to quantify the distribution of household transmissions directly from a single infected household
member, where ğ‘¦ is the number of transmissions, ğ‘§ is the number of susceptible household members, ğ‘ = ğ‘â„ , and
ğ‘‘ = ğ‘‘â„ . In our alternate model we also use ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) to quantify the distribution of community acquisitions among
members of a household from non-household members, where ğ‘¦ is the number of community acquisitions, ğ‘§ is the
total number of household members, ğ‘ = ğ‘ğ‘ , and ğ‘‘ = ğ‘‘ğ‘ .
Here, we derive the formula for ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) at the boundaries of the range of possible values for ğ‘‘: ğ‘‘ â†’ âˆ and ğ‘‘ â†’ 0.
To do this, we rewrite ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) in an alternate form. First, using the property B(ğ‘¥, ğ‘¦) = Î“(ğ‘¥)Î“(ğ‘¦)â„Î“(ğ‘¥ + ğ‘¦):
ğ‘§
ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) = (ğ‘¦)

Î“(ğ‘‘) Î“(ğ‘¦ + ğ‘‘ğ‘) Î“(ğ‘§ âˆ’ ğ‘¦ + ğ‘‘(1 âˆ’ ğ‘))
Î“(ğ‘§ + ğ‘‘) Î“(ğ‘‘ğ‘)
Î“(ğ‘‘(1 âˆ’ ğ‘))

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Then using the property, for positive integer ğ‘›, Î“(ğ‘§ + ğ‘›) = ğ‘§(ğ‘§ + 1) â‹¯ (ğ‘§ + ğ‘› âˆ’ 1)Î“(ğ‘§):
ğ‘‘(1 âˆ’ ğ‘)(ğ‘‘(1 âˆ’ ğ‘) + 1) â‹¯ (ğ‘‘(1 âˆ’ ğ‘) + ğ‘§ âˆ’ 1)
ğ‘¦=0
ğ‘‘(ğ‘‘ + 1) â‹¯ (ğ‘‘ + ğ‘§ âˆ’ 1)
ğ‘§ [ğ‘‘ğ‘(ğ‘‘ğ‘ + 1) â‹¯ (ğ‘‘ğ‘ + ğ‘¦ âˆ’ 1)][ğ‘‘(1 âˆ’ ğ‘)(ğ‘‘(1 âˆ’ ğ‘) + 1) â‹¯ (ğ‘‘(1 âˆ’ ğ‘) + ğ‘§ âˆ’ ğ‘¦ âˆ’ 1)]
ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) = (ğ‘¦)
0<ğ‘¦<ğ‘§
ğ‘‘(ğ‘‘ + 1) â‹¯ (ğ‘‘ + ğ‘§ âˆ’ 1)
ğ‘‘ğ‘(ğ‘‘ğ‘ + 1) â‹¯ (ğ‘‘ğ‘ + ğ‘§ âˆ’ 1)
ğ‘¦=ğ‘§
{
ğ‘‘(ğ‘‘ + 1) â‹¯ (ğ‘‘ + ğ‘§ âˆ’ 1)
In the following we rewrite the numerators and denominators in powers of ğ‘‘. Only the lowest and highest powers of
ğ‘‘ will matter for taking the limits that follow, so the other terms within â€œâ‹¯â€ are not shown.
(1 âˆ’ ğ‘)(ğ‘§ âˆ’ 1)! ğ‘‘ + â‹¯ + (1 âˆ’ ğ‘)ğ‘§ ğ‘‘ ğ‘§
(ğ‘§ âˆ’ 1)! ğ‘‘ + â‹¯ + ğ‘‘ ğ‘§
ğ‘§ ğ‘(1 âˆ’ ğ‘)(ğ‘¦ âˆ’ 1)! (ğ‘§ âˆ’ ğ‘¦ âˆ’ 1)! ğ‘‘ 2 + â‹¯ + ğ‘ ğ‘¦ (1 âˆ’ ğ‘)ğ‘§âˆ’ğ‘¦ ğ‘‘ ğ‘§
ğ¹ğ‘¦ğ‘§ (ğ‘, ğ‘‘) = (ğ‘¦)
(ğ‘§ âˆ’ 1)! ğ‘‘ + â‹¯ + ğ‘‘ ğ‘§
ğ‘(ğ‘§ âˆ’ 1)! ğ‘‘ + â‹¯ + ğ‘ ğ‘§ ğ‘‘ ğ‘§
(ğ‘§ âˆ’ 1)! ğ‘‘ + â‹¯ + ğ‘‘ ğ‘§
{

ğ‘¦=0
0<ğ‘¦<ğ‘§
ğ‘¦=ğ‘§

When taking the limit ğ‘‘ â†’ âˆ, we note that each fraction has highest order ğ‘‘ ğ‘§ in both numerator and denominator,
so the limit will be the ratio of the coefficients of that term:
ğ‘§ B(ğ‘¦ + ğ‘‘ğ‘, ğ‘§ âˆ’ ğ‘¦ + ğ‘‘(1 âˆ’ ğ‘))

lim (ğ‘¦)

ğ‘‘â†’âˆ

B(ğ‘‘ğ‘, ğ‘‘(1 âˆ’ ğ‘))

ğ‘§

= (ğ‘¦) ğ‘ ğ‘¦ (1 âˆ’ ğ‘)ğ‘§âˆ’ğ‘¦

When taking the limit ğ‘‘ â†’ 0, we note that the fraction for cases ğ‘¦ = 0 and ğ‘¦ = ğ‘§ have lowest order term ğ‘‘ in both
the numerator and denominator, so the limit will be the ratio of the coefficients on those terms. The fraction for the
0 < ğ‘¦ < ğ‘§ case has only powers of ğ‘‘ 2 and higher in the numerator, and a nonzero ğ‘‘ term in the denominator, so the
limit is 0:
1 âˆ’ ğ‘,
ğ‘¦=0
ğ‘§ B(ğ‘¦ + ğ‘‘ğ‘, ğ‘§ âˆ’ ğ‘¦ + ğ‘‘(1 âˆ’ ğ‘))
0<ğ‘¦<ğ‘§
lim (ğ‘¦)
= { 0,
ğ‘‘â†’0
B(ğ‘‘ğ‘, ğ‘‘(1 âˆ’ ğ‘))
ğ‘,
ğ‘¦=ğ‘§
Direct transmission probabilities ğ‘¯ğ’™ğ’šğ’›
Here we derive the formulae for ğ»ğ‘¥ğ‘¦ğ‘§ : the probability of ğ‘¦ transmissions to ğ‘§ susceptible household members
directly from ğ‘¥ infected members

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

As described in the main text, we first define the probabilities for transmissions directly from ğ‘¥ = 1 infected
household member:

ğ»1ğ‘¦ğ‘§

1 âˆ’ ğ‘â„ ,
ğ‘¦=0
0 < ğ‘¦ < ğ‘§,
{ 0,
ğ‘‘â„ = 0
ğ‘â„ ,
ğ‘¦=ğ‘§
= ğ¹ğ‘¦ğ‘§ (ğ‘â„ , ğ‘‘â„ ) = ğ‘§ B(ğ‘¦ + ğ‘‘â„ ğ‘â„ , ğ‘§ âˆ’ ğ‘¦ + ğ‘‘â„ (1 âˆ’ ğ‘â„ ))
, 0 < ğ‘‘â„ < âˆ
(ğ‘¦ )
B(ğ‘‘â„ ğ‘â„ , ğ‘‘â„ (1 âˆ’ ğ‘â„ ))
ğ‘§
ğ‘‘â„ = âˆ
(ğ‘¦) ğ‘â„ ğ‘¦ (1 âˆ’ ğ‘â„ )ğ‘§âˆ’ğ‘¦ ,
{

Next consider ğ‘¥ = 2 infected household members. The probability that ğ‘¦ = 0 transmissions occur is the probability
that both infected members transmit to 0 others: ğ»20ğ‘§ = ğ»10ğ‘§ ğ»10ğ‘§ . To calculate the probability that ğ‘¦ > 0
transmissions occur from the two infected members, it is convenient to consider the two infected individuals having
transmission opportunities in sequence, say A followed by B. If A transmits to any household members, this reduces
the number of susceptible members remaining for B to infect. For example, the probability that ğ‘¦ = 1 is the
probability that A transmits to 0 of ğ‘§ and B transmits to 1 of ğ‘§, plus the probability that A transmits to 1 of ğ‘§ and B
transmits to 0 of ğ‘§ âˆ’ 1 remaining susceptible members: ğ»21ğ‘§ = ğ»10ğ‘§ ğ»11ğ‘§ + ğ»11ğ‘§ ğ»1,0,ğ‘§âˆ’1 . The calculation follows a
similar pattern for ğ‘¦ = 2: ğ»22ğ‘§ = ğ»10ğ‘§ ğ»12ğ‘§ + ğ»11ğ‘§ ğ»1,1,ğ‘§âˆ’1 + ğ»12ğ‘§ ğ»1,0,ğ‘§âˆ’2 . It follows that:
ğ‘¦

ğ»2ğ‘¦ğ‘§ = âˆ‘ ğ»1ğ‘–ğ‘§ ğ»1,ğ‘¦âˆ’ğ‘–,ğ‘§âˆ’ğ‘–
ğ‘–=0

Now for ğ‘¥ = 3 infected household members, we can use the fact that we have already calculated ğ»2ğ‘¦ğ‘§ , which covers
the transmission probabilities from two of the three infected members, and then we include the probability that third
member transmits to any remaining susceptible members that the first two did not infect:
ğ‘¦

ğ»3ğ‘¦ğ‘§ = âˆ‘ ğ»2ğ‘–ğ‘§ ğ»1,ğ‘¦âˆ’ğ‘–,ğ‘§âˆ’ğ‘–
ğ‘–=0

Following this pattern, we continue calculating ğ»ğ‘¥ğ‘¦ğ‘§ for each ğ‘¥ in increasing sequence:
ğ‘¦

ğ»ğ‘¥ğ‘¦ğ‘§ = âˆ‘ ğ»ğ‘¥âˆ’1,ğ‘–,ğ‘§ ğ»1,ğ‘¦âˆ’ğ‘–,ğ‘§âˆ’ğ‘–
ğ‘–=0

Total transmission probabilities ğ‘»ğ’™ğ’šğ’›

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Here we derive the formulae for ğ‘‡ğ‘¥ğ‘¦ğ‘§ : the probability of ğ‘¦ total transmissions to ğ‘§ initially susceptible members
from ğ‘¥ initially infected members. In other words, ğ‘‡ğ‘¥ğ‘¦ğ‘§ is the probability that the final household outbreak size is
ğ‘¥ + ğ‘¦, given that ğ‘¥ household members were initially infected and ğ‘§ household members were initially susceptible.
First, we note that ğ‘‡ğ‘¥0ğ‘§ = ğ»ğ‘¥0ğ‘§ for all possible (ğ‘¥, ğ‘§) pairs, because if the initial ğ‘¥ infected members do not transmit
to anyone (ğ‘¦ = 0), the household outbreak is over and the final size has been reached. Next we consider the
probability of ğ‘¦ = 1 total transmissions, which occurs when the initial ğ‘¥ infected members transmit directly to 1
other (with probability ğ»ğ‘¥1ğ‘§ ), who then does not subsequently transmit to any of the remaining ğ‘§ âˆ’ 1 susceptible
members (with probability ğ»1,0,ğ‘§âˆ’1 = ğ‘‡1,0,ğ‘§âˆ’1 ). Hence,
ğ‘‡ğ‘¥1ğ‘§ = ğ»ğ‘¥1ğ‘§ ğ‘‡1,0,ğ‘§âˆ’1
For ğ‘¦ = 2 total transmissions, we must include the probability that the initial ğ‘¥ infected members transmit directly to
2 others who then transmit to none and the probability that the initial ğ‘¥ infected members transmit directly to 1 other
who then produces an outbreak among the remaining susceptible members with 1 total transmission:
ğ‘‡ğ‘¥2ğ‘§ = ğ»ğ‘¥2ğ‘§ ğ‘‡2,0,ğ‘§âˆ’2 + ğ»ğ‘¥1ğ‘§ ğ‘‡1,1,ğ‘§âˆ’1
Following similar logic for ğ‘¦ = 3, and making use of the ğ‘‡ğ‘¥0ğ‘§ , ğ‘‡ğ‘¥1ğ‘§ , and ğ‘‡ğ‘¥2ğ‘§ values already calculated, we arrive at:
ğ‘‡ğ‘¥3ğ‘§ = ğ»ğ‘¥3ğ‘§ ğ‘‡3,0,ğ‘§âˆ’3 + ğ»ğ‘¥2ğ‘§ ğ‘‡2,1,ğ‘§âˆ’2 + ğ»ğ‘¥1ğ‘§ ğ‘‡1,2,ğ‘§âˆ’1
The general formula calculated for increasing values of ğ‘¦ is:
ğ‘¦âˆ’1

ğ‘‡ğ‘¥ğ‘¦ğ‘§ = âˆ‘ ğ»ğ‘¥,ğ‘¦âˆ’ğ‘–,ğ‘§ ğ‘‡ğ‘¦âˆ’ğ‘–,ğ‘–,ğ‘§âˆ’ğ‘¦+ğ‘–
ğ‘–=0

Within-household reproduction numbers and threshold condition
We define the within-household reproduction number ğ‘…â„ as the expected number of household transmissions
directly from an infected person who acquired infection in the community and has no non-susceptible housemates.
Let â„ğ‘– be the fraction of households with size ğ‘–, up to a maximum size ğ‘. Then the mean ğœ‡ and variance ğœ 2 of the
household size distribution are

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

ğ‘

ğ‘

ğœ‡ = âˆ‘(ğ‘–â„ğ‘– ) ,

2

ğœ = âˆ‘(ğ‘– 2 â„ğ‘– ) âˆ’ ğœ‡2

ğ‘–=1

ğ‘–=1

Let ğ‘ğ‘– be the probability that a randomly chosen person has ğ‘– housemates. The probability that a randomly chosen
person lives in a house of total size ğ‘– (including themselves) is ğ‘–â„ğ‘– â„ğœ‡, so
ğ‘ğ‘– = (ğ‘– + 1)â„ğ‘–+1 â„ğœ‡
Then ğ‘…â„ is ğ‘â„ times the mean number of housemates of a randomly chosen person:
ğ‘âˆ’1

ğ‘

ğ‘

ğ‘…â„ = ğ‘â„ âˆ‘(ğ‘–ğ‘ğ‘– ) = ğ‘â„ (âˆ‘(ğ‘– 2 â„ğ‘– ) âˆ’ âˆ‘(ğ‘–â„ğ‘– ))â„ğœ‡ = ğ‘â„ (ğœ‡ + ğœ 2 â„ğœ‡ âˆ’ 1)
ğ‘–=1

ğ‘–=1

ğ‘–=1

We also define an alternate within-household reproduction number ğ‘…â„âˆ— as the expected total number of transmissions
in the household of an infected person who acquired infection in the community and has no initially non-susceptible
housemates. Given that a person acquiring infection in the community has ğ‘– susceptible housemates, the probability
that ğ‘— of their housemates become infected before the household outbreak terminates is ğ‘‡1ğ‘—ğ‘– (ğ‘â„ , ğ‘‘â„ ), as defined in
Section 2.2 of the main text. The expected total number of transmissions in their household will be then be
âˆ‘ğ‘–ğ‘—=1 ğ‘—ğ‘‡1ğ‘—ğ‘– (ğ‘â„ , ğ‘‘â„ ). So, the household reproduction number formula is:

ğ‘…â„âˆ—

ğ‘âˆ’1

ğ‘–

ğ‘âˆ’1

ğ‘–

ğ‘–=1

ğ‘—=1

ğ‘–=1

ğ‘—=1

(ğ‘– + 1)â„ğ‘–+1
= âˆ‘ ğ‘ğ‘– âˆ‘ ğ‘—ğ‘‡1ğ‘—ğ‘– (ğ‘â„ , ğ‘‘â„ ) = âˆ‘
âˆ‘ ğ‘—ğ‘‡1ğ‘—ğ‘– (ğ‘â„ , ğ‘‘â„ )
ğœ‡

For the high-variability boundary case at ğ‘‘â„ = 0, we have that
ğ‘–

âˆ‘ ğ‘—ğ‘‡1ğ‘—ğ‘– (ğ‘â„ , 0) = ğ‘–ğ‘â„
ğ‘—=1

because ğ‘‡1ğ‘—ğ‘– (ğ‘â„ , 0) = ğ‘â„ when ğ‘— = ğ‘– and 0 for other nonzero values of ğ‘— (reflecting all-or-nothing transmission). It
follows that ğ‘…â„ = ğ‘…â„âˆ— when ğ‘‘â„ = 0. This makes intuitive sense because in the all-or-nothing scenario, when the
index person transmits, all in the household are infected directly, and there is no one left to infect in subsequent
generations, so the final household outbreak size is entirely reflected in ğ‘…â„ .

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

We next investigate the implications of our ğ‘…â„âˆ— estimate for population-wide transmission control. The threshold
condition delineating subcritical and supercritical transmission in the population occurs when the maximal
eigenvalue of the matrix
ğ‘…
[ ğ‘
ğ‘…ğ‘

ğ‘…â„âˆ—
]
0

exceeds one [30]. Here, ğ‘…ğ‘ is defined as the average number of community transmissions per infected individual
(i.e., average number of transmissions to people not in the infected individualâ€™s household). The occurrence of ğ‘…ğ‘ in
both rows of the matrix reflects an assumption that its value applies to the transmissibility of people who acquire
their own infection in the community and in their household. The zero element in the lower-right corner of the
matrix reflects the fact that the ğ‘…â„âˆ— people on average who acquire infection in their household do not transmit
further in their household, by definition, because ğ‘…â„âˆ— was derived from the final household outbreak size equations
encompassed in ğ‘‡ğ‘¥ğ‘¦ğ‘§ .
The maximal eigenvalue exceeding one produces the following threshold condition:
ğ‘…ğ‘
(1 + âˆš1 + 4 ğ‘…â„âˆ— â„ğ‘…ğ‘ ) > 1
2
This is equivalent to
ğ‘…ğ‘ (ğ‘…â„âˆ— + 1) > 1
If the threshold condition is met and ğ‘…â„âˆ— is fixed, then the system can be pushed below threshold by reducing ğ‘…ğ‘ such
that

ğ‘…ğ‘ <

ğ‘…â„âˆ—

1
+1

If ğ‘…ğ‘ is fixed and less than one, then the system can be pushed below threshold by reducing ğ‘…â„âˆ— such that
ğ‘…â„âˆ— <

1
âˆ’1
ğ‘…ğ‘

Relationship between beta distributed probability and dynamic transmission parameters

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

If an infected personâ€™s duration of infectiousness is ğœ and the transmission rate to a contact is ğ›½, the probability that
transmission to the contact occurs is ğ‘ = 1 âˆ’ ğ‘’ âˆ’ğ›½ğœ . We assume ğœ is fixed and ğ›½ is a gamma distributed random
variable with shape ğ‘˜ and rate ğ‘Ÿ. Then, the first and second moments of the random variable ğ‘ are:
âˆ

E[ğ‘] = âˆ«
0

âˆ

E[ğ‘2 ] = âˆ«
0

ğ‘Ÿ ğ‘˜ ğ‘˜âˆ’1 âˆ’ğ‘Ÿğ‘¥
ğ‘Ÿ ğ‘˜
ğ‘¥ ğ‘’ (1 âˆ’ ğ‘’ âˆ’ğœğ‘¥ )ğ‘‘ğ‘¥ = 1 âˆ’ (
)
Î“(ğ‘˜)
ğ‘Ÿ+ğœ

ğ‘˜
ğ‘Ÿ ğ‘˜ ğ‘˜âˆ’1 âˆ’ğ‘Ÿğ‘¥
ğ‘Ÿ ğ‘˜
ğ‘Ÿ
ğ‘¥ ğ‘’ (1 âˆ’ ğ‘’ âˆ’ğœğ‘¥ )2 ğ‘‘ğ‘¥ = 1 âˆ’ 2 (
) +(
)
Î“(ğ‘˜)
ğ‘Ÿ+ğœ
ğ‘Ÿ + 2ğœ

The variance is then

Var[ğ‘] = E[ğ‘2 ] âˆ’ (E[ğ‘])2 = (

ğ‘˜
ğ‘Ÿ
ğ‘Ÿ 2ğ‘˜
) âˆ’(
)
ğ‘Ÿ + 2ğœ
ğ‘Ÿ+ğœ

We then equate the mean and variance to those of the beta distribution with mean ğ‘â„ and dispersion ğ‘‘â„ , which we
used in our MLE model in the main text.

ğ‘â„ = 1 âˆ’ (

ğ‘Ÿ ğ‘˜
)
ğ‘Ÿ+ğœ

ğ‘˜
ğ‘â„ (1 âˆ’ ğ‘â„ )
ğ‘Ÿ
ğ‘Ÿ 2ğ‘˜
=(
) âˆ’(
)
ğ‘‘â„ + 1
ğ‘Ÿ + 2ğœ
ğ‘Ÿ+ğœ

Combining those two equations yields
((1 âˆ’ ğ‘â„ )ğ‘‘â„ + 1)

1 â„ğ‘˜

(2 âˆ’ (1 âˆ’ ğ‘â„ )1â„ğ‘˜ ) âˆ’ (ğ‘‘â„ + 1)1â„ğ‘˜ = 0

ğ‘Ÿ=

ğœ(1 âˆ’ ğ‘â„ )1â„ğ‘˜
1 âˆ’ (1 âˆ’ ğ‘â„ )1â„ğ‘˜

We solved the first equation for ğ‘˜, which is independent of the assumption for ğœ, using our MLE estimates of ğ‘â„ and
ğ‘‘â„ . We applied each of the (ğ‘â„ , ğ‘‘â„ ) pairs from our parametric bootstrap analysis to this equation to derive the
confidence interval for ğ‘˜.
Supplemental Results
The alternate model produced an estimate for the new dispersion parameter ğ‘‘ğ‘ = 2.1 (0.89 â€“ 7.5) and altered
estimates for the other 7 parameters compared to their values for the main text model (Table S4). The log likelihood

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

at this MLE was about 1 greater than the log likelihood produced by the main text result (Table S5), suggesting that
the main text model (equivalent to the alternate model with ğ‘‘ğ‘ = âˆ) cannot be rejected with high confidence in
favor of the alternate model by the likelihood ratio test (P = 0.14). The Bayesian information criterion (BIC) for the
alternate model is 2418.5 compared to 2411.6 for the main text (ğ‘‘ğ‘ = âˆ) model, which favors the main text model
with a BIC difference of 6.9.
The conclusion of high household transmission variability from the main-text model is consistent under this
alternate model, with the MLE occurring at low value of the dispersion parameter ğ‘‘â„ = 0.30, and the low-variability
binomial model ğ‘‘â„ = âˆ can be rejected with P = 0.02. However, uncertainty ranges become wider at higher levels
of overdispersion in household risk of community acquisition. This is illustrated by the fact that a model assuming
no household transmission (ğ‘â„ = 0), i.e. all household cases explained by acquisitions outside the households with
high overdispersion (ğ‘‘ğ‘ = 0.5), cannot be rejected with very high confidence (P = 0.068). Thus, the alternate
explanation for the distribution of household cases may not be definitively ruled out by our data.

Table S1. Fraction of household data from each county in the state of Utah
Data

Utah population

Cache County

11.1%

4.0%

Davis County

11.4%

11.2%

Salt Lake County

41.5%

36.6%

Summit County

3.1%

1.3%

Utah County

12.5%

19.6%

Washington County

11.4%

5.4%

Weber County

8.9%

8.1%

Other 22 Counties

0.0%

13.9%

Data refers to the fraction of households that contributed serology data for antibody testing; Utah population refers to the fraction of the overall
state population that resides in each county (US Census data).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Table S2. Intervals between reported prior positive test and antibody test results
Interval range

Number

Number antibody positive

1 â€“ 7 days

3

0

8 â€“ 14 days

11

9

15 â€“ 21 days

10

9

22 â€“ 28 days

10

9

29 â€“ 35 days

8

6

36 â€“ 42 days

10

6

43 â€“ 56 days

10

9

57 â€“ 70 days

7

6

71 â€“ 129 days

6

4

Number in middle column is the count of individuals whose reported date of a prior positive test occurred within the given range of days before
the date of antibody testing, and the third column gives the number of those who tested positive for antibodies.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Table S3. Demographic distributions of surveyed individuals
Data

Utah

U.S.

Age and Sex
Age 0 to 4 years

1.6%

7.7%

6.1%

Age 5 to 14 years

6.6%

16.4%

12.6%

Age 15 to 24 years

13.2%

16.2%

13.0%

Age 25 to 34 years

15.8%

14.7%

14.0%

Age 35 to 44 years

16.6%

13.8%

12.6%

Age 45 to 54 years

12.5%

10.2%

12.6%

Age 55 to 64 years

13.8%

9.5%

12.8%

Age 65 to 74 years

13.0%

6.8%

9.8%

Age 75 to 84 years

5.7%

3.4%

4.8%

Age 85 years and over

1.2%

1.2%

1.8%

52.0%

49.6%

50.8%

Female persons
Race and Hispanic Origin
White alone

93.8%

90.6%

76.3%

Black or African American alone

0.7%

1.5%

13.4%

American Indian and Alaska Native alone

0.6%

1.6%

1.3%

Asian alone

2.3%

2.7%

5.9%

Native Hawaiian and Other Pacific Islander alone

0.5%

1.1%

0.2%

Two or More Races

2.0%

2.6%

2.8%

Hispanic or Latino

8.5%

14.4%

18.5%

87.9%

77.8%

60.1%

High school graduate or higher, persons age 25+

98.2%

92.3%

88.0%

Bachelorâ€™s degree or higher, persons age 25+

57.1%

34.0%

32.1%

White alone, not Hispanic or Latino
Education

Data refers to the fraction of surveyed individuals who reported each characteristic in our survey results. Utah and U.S. columns contain data
from the US Census (Vintage 2019 Population Estimates Program).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Table S4. Alternate model results: allowing variability in importation probability by household
Value

MLE estimate (95% interval)

Mean community acquisition probability (ğ‘ğ‘ )

0.56% (0.44% â€“ 0.70%)

Household community acquisition dispersion (ğ‘‘ğ‘ )

2.1 (0.89 â€“ 7.5)

Mean per-capita household transmission probability (ğ‘â„ )

27% (16% â€“ 41%)

Per-capita household transmission dispersion (ğ‘‘â„ )

0.21 (0 â€“ 3.4)

Probability that surveyed, infected person reported a prior positive test (ğœ™ğ‘‰ )

72% (62% â€“ 82%)

Probability that antibody test of person with prior infection was positive (ğœ™ğ´ )

87% (77% â€“ 94%)

Probability that surveyed, uninfected person did not report a prior positive test (ğœ‹ğ‘‰ )

99.92% (99.86% â€“ 99.97%)

Probability that antibody test of person with no prior infection was negative (ğœ‹ğ´ )

99.3% (99.2% â€“ 99.5%)

Confidence intervals for MLE derived from the likelihood ratio test, varying each individual parameter while fixing other parameters at their
MLE values.

Table S5. Comparison of alternate model MLE to main-text and other models
Fixed

ğ‘Ì‚ğ‘

ğ‘‘Ì‚ğ‘

ğ‘Ì‚â„

ğ‘‘Ì‚â„

ğœ™Ì‚ğ‘‰

ğœ™Ì‚ğ´

ğœ‹Ì‚ğ‘‰

ğœ‹Ì‚ğ´

values

Log

# of optimized

Rejection

likelihood

parameters

P value

None

0.56%

2.1

27%

0.21

72%

87%

99.92%

99.3%

âˆ’1172.75

8

-

ğ‘‘ğ‘ = âˆ

0.41%

âˆ*

36%

0.43

72%

86%

99.94%

99.3%

âˆ’1173.84

7

0.14

ğ‘‘â„ = 0

0.60%

1.7

24%

0*

72%

87%

99.93%

99.3%

âˆ’1172.86

7

0.64

ğ‘‘â„ = âˆ

0.77%

0.5

0%

âˆ*

72%

88%

99.92%

99.3%

âˆ’1175.29

7

0.024

ğ‘â„ = 0%

0.77%

0.5

0%*

N/A

72%

88%

99.92%

99.3%

âˆ’1175.29

6

0.079

*Values that were fixed for the model in that row; other relevant values were optimized by MLE. P values were derived from the likelihood ratio
test, compared to the likelihood of the overall MLE in the top row: twice the difference in log likelihood compared to the chi-squared distribution
with degrees of freedom equal to the difference in the number of optimized parameters. The model with household transmission probability ğ‘â„
fixed at 0% optimized only 6 parameters because the transmission dispersion parameter ğ‘‘â„ is irrelevant with no transmission, hence we used 2
degrees of freedom for the reference chi-squared distribution when comparing the likelihood to the full 8-parameter model. For the model with ğ‘‘â„
fixed at âˆ (binomial transmission model), the optimum occurred at the boundary ğ‘â„ = 0, producing the same likelihood as the adjacent model but
different P-value as the reference chi-squared distribution has 1 degree of freedom.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Figure S1. Two-dimension confidence regions for ğ‘ğ‘ paired with each other parameter

Solid curves are the 2-dimensional confidence regions derived from the likelihood ratio test, comparing the likelihood ratio statistic to the 95 th
percentile of the chi-squared distribution with 2 degrees of freedom. Large solid circle is the MLE estimate and dashed lines are the confidence
intervals for each individual parameter derived from the likelihood ratio test (Table 1 main text). Small dots are the MLE estimates from each of
500 simulated data sets generated using parameter values set at the MLE from the actual data (parametric bootstrap).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Figure S2. Two-dimension confidence regions for ğ‘â„ paired with each other parameter

Solid curves are the 2-dimensional confidence regions derived from the likelihood ratio test, comparing the likelihood ratio statistic to the 95 th
percentile of the chi-squared distribution with 2 degrees of freedom. Large solid circle is the MLE estimate and dashed lines are the confidence
intervals for each individual parameter derived from the likelihood ratio test (Table 1 main text). Small dots are the MLE estimates from each of
500 simulated data sets generated using parameter values set at the MLE from the actual data (parametric bootstrap).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Figure S3. Two-dimension confidence regions for ğ‘‘â„ paired with each other parameter

Solid curves are the 2-dimensional confidence regions derived from the likelihood ratio test, comparing the likelihood ratio statistic to the 95 th
percentile of the chi-squared distribution with 2 degrees of freedom. Large solid circle is the MLE estimate and dashed lines are the confidence
intervals for each individual parameter derived from the likelihood ratio test (Table 1 main text). Small dots are the MLE estimates from each of
500 simulated data sets generated using parameter values set at the MLE from the actual data (parametric bootstrap).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Figure S4. Two-dimension confidence regions for ğœ™ğ‘‰ paired with each other parameter

Solid curves are the 2-dimensional confidence regions derived from the likelihood ratio test, comparing the likelihood ratio statistic to the 95 th
percentile of the chi-squared distribution with 2 degrees of freedom. Large solid circle is the MLE estimate and dashed lines are the confidence
intervals for each individual parameter derived from the likelihood ratio test (Table 1 main text). Small dots are the MLE estimates from each of
500 simulated data sets generated using parameter values set at the MLE from the actual data (parametric bootstrap).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Figure S5. Two-dimension confidence regions for ğœ™ğ´ paired with each other parameter

Solid curves are the 2-dimensional confidence regions derived from the likelihood ratio test, comparing the likelihood ratio statistic to the 95th
percentile of the chi-squared distribution with 2 degrees of freedom. Large solid circle is the MLE estimate and dashed lines are the confidence
intervals for each individual parameter derived from the likelihood ratio test (Table 1 main text). Small dots are the MLE estimates from each of
500 simulated data sets generated using parameter values set at the MLE from the actual data (parametric bootstrap).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Figure S6. Two-dimension confidence regions for ğœ‹ğ‘‰ paired with each other parameter

Solid curves are the 2-dimensional confidence regions derived from the likelihood ratio test, comparing the likelihood ratio statistic to the 95 th
percentile of the chi-squared distribution with 2 degrees of freedom. Large solid circle is the MLE estimate and dashed lines are the confidence
intervals for each individual parameter derived from the likelihood ratio test (Table 1 main text). Small dots are the MLE estimates from each of
500 simulated data sets generated using parameter values set at the MLE from the actual data (parametric bootstrap).

medRxiv preprint doi: https://doi.org/10.1101/2021.01.29.20248797; this version posted June 30, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
for use under a CC0 license.

Figure S7. Two-dimension confidence regions for ğœ‹ğ´ paired with each other parameter

Solid curves are the 2-dimensional confidence regions derived from the likelihood ratio test, comparing the likelihood ratio statistic to the 95th
percentile of the chi-squared distribution with 2 degrees of freedom. Large solid circle is the MLE estimate and dashed lines are the confidence
intervals for each individual parameter derived from the likelihood ratio test (Table 1 main text). Small dots are the MLE estimates from each of
500 simulated data sets generated using parameter values set at the MLE from the actual data (parametric bootstrap).

